10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2012

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 001-34950

SABRA HEALTH CARE REIT, INC.

(Exact Name of Registrant as Specified in Its Charter)

Maryland	27-2560479
(State of Incorporation)	(I.R.S. Employer Identification No.)

18500 Von Karman Avenue, Suite 550

Irvine, CA 92612

(888) 393-8248

(Address, zip code and telephone number of Registrant)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	o	Accelerated filer	x
Non-accelerated filer	o  (Do not check if a smaller reporting company)	Smaller reporting company	o

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o    No  x

As of May 1, 2012, there were 37,051,242 shares of the Registrant’s $0.01 par value Common Stock outstanding.

SABRA HEALTH CARE REIT, INC. AND SUBSIDIARIES

Index

		Page Numbers
PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements:
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Income	4
	Condensed Consolidated Statements of Stockholders’ Equity	5
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	31
Item 4.	Controls and Procedures	32
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	33
Item 1a.	Risk Factors	33
Item 6.	Exhibits	33
Signatures		35

1

References throughout this document to “Sabra,” “we,” “our,” “ours” and “us” refer to Sabra Health Care REIT, Inc. and its direct and indirect consolidated subsidiaries and not any other person.

STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Certain statements in this Quarterly Report on Form 10-Q (this “10-Q”) contain “forward-looking” information as that term is defined by the Private Securities Litigation Reform Act of 1995. Examples of forward-looking statements include all statements regarding our expected future financial position, results of operations, cash flows, liquidity, financing plans, business strategy, budgets, the expected amounts and timing of dividends and other distributions, projected expenses and capital expenditures, competitive position, growth opportunities, potential acquisitions, plans and objectives for future operations, and compliance with and changes in governmental regulations. You can identify some of the forward-looking statements by the use of forward-looking words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “intend,” “should,” “may” and other similar expressions, although not all forward-looking statements contain these identifying words.

Our actual results may differ materially from those projected or contemplated by our forward-looking statements as a result of various factors, including, among others, the following:

• our dependence on Sun Healthcare Group, Inc. until we are able to further diversify our portfolio;

• our dependence on the operating success of our tenants;

• changes in general economic conditions and volatility in financial and credit markets;

• the dependence of our tenants on reimbursement from governmental and other third-party payors;

• the significant amount of and our ability to service our indebtedness;

• covenants in our debt agreements that may restrict our ability to make acquisitions, incur additional indebtedness and refinance indebtedness on favorable terms;

• increases in market interest rates;

• our ability to raise capital through equity financings;

• the relatively illiquid nature of real estate investments;

• competitive conditions in our industry;

• the loss of key management personnel or other employees;

• the impact of litigation and rising insurance costs on the business of our tenants;

• uninsured or underinsured losses affecting our properties and the possibility of environmental compliance costs and liabilities;

• our ability to qualify and maintain our status as a REIT; and

• compliance with REIT requirements and certain tax matters related to status as a REIT.

We urge you to carefully consider these risks and review the additional disclosures we make concerning risks and other factors that may affect our business and operating results, including those referred to in Part I, Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2011 (our “2011 Annual Report on Form 10-K”), as such risk factors may be amended, supplemented or superseded from time to time by other reports we file with the Securities and Exchange Commission (the “SEC”) in the future, including subsequent Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. We caution you that any forward-looking statements made in this 10-Q are not guarantees of future performance and you should not place undue reliance on these forward-looking statements, which speak only as of the date of this report. We do not intend, and we undertake no obligation, to update any forward-looking information to reflect events or circumstances after the date of this 10-Q or to reflect the occurrence of unanticipated events, unless required by law to do so.

SUN HEALTHCARE GROUP, INC. INFORMATION

This 10-Q includes information regarding Sun Healthcare Group, Inc. (formerly known as SHG Services, Inc.; “Sun”), a Delaware corporation. Sun is subject to the reporting requirements of the SEC and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. The information related to Sun provided in this 10-Q has been provided by Sun or derived from its public filings. We have not independently verified this information. We have no reason to believe that such information is inaccurate in any material respect. We are providing this data for informational purposes only. Sun’s filings with the SEC can be found at www.sec.gov.

2

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

SABRA HEALTH CARE REIT, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(dollars in thousands, except per share data)

	March 31, 2012			December 31, 2011
	(unaudited)
Assets
Real estate investments, net of accumulated depreciation of $116,166 and $108,916 as of March 31, 2012 and December 31, 2011, respectively	$	680,635		$	658,377
Cash and cash equivalents	2,675			42,250
Restricted cash	6,664			6,093
Deferred tax assets	25,540			25,540
Prepaid expenses, deferred financing costs and other assets	31,031			17,390
Total assets	$	746,545		$	749,650
Liabilities and stockholders’ equity
Mortgage notes payable	$	157,603		$	158,398
Senior unsecured notes payable	225,000			225,000
Accounts payable and accrued liabilities	17,804			14,139
Tax liability	25,540			25,540
Total liabilities	425,947			423,077
Commitments and contingencies (Note 11)
Stockholders’ equity
Preferred stock, $.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of March 31, 2012 and December 31, 2011	—			—
Common stock, $.01 par value; 125,000,000 shares authorized, 37,009,602 and 36,891,712 shares issued and outstanding as of March 31, 2012 and December 31, 2011, respectively	370			369
Additional paid-in capital	346,827			344,995
Cumulative distributions in excess of net income	(26,599		)	(18,791		)
Total stockholders’ equity	320,598			326,573
Total liabilities and stockholders’ equity	$	746,545		$	749,650

See accompanying notes to condensed consolidated financial statements.

3

SABRA HEALTH CARE REIT, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(dollars in thousands, except per share data)

(unaudited)

	Three Months Ended March 31,
	2012		2011
Revenues:
Rental income	$	23,663	$	17,561
Interest income	64		40
Total revenues	23,727		17,601
Expenses:
Depreciation and amortization	7,303		6,086
Interest	7,698		7,597
General and administrative	4,321		2,670
Total expenses	19,322		16,353
Net income	$	4,405	$	1,248
Net income per common share, basic	$	0.12	$	0.05
Net income per common share, diluted	$	0.12	$	0.05
Weighted-average number of common shares outstanding, basic	37,035,970		25,136,140
Weighted-average number of common shares outstanding, diluted	37,058,886		25,211,585
Dividends per common share	$	0.33	$	—

See accompanying notes to condensed consolidated financial statements.

4

SABRA HEALTH CARE REIT, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(dollars in thousands, except per share data)

(unaudited)

	Common Stock			Additional Paid-in Capital			Cumulative Distributions in Excess of Net Income			Total Stockholders’ Equity
	Shares	Amounts
Balance, December 31, 2010	25,061,072	$	251	$	177,275		$	7		$	177,533
Net income	—	—		—			1,248			1,248
Amortization of stock-based compensation	—	—		1,142			—			1,142
Stock issuance	23,662	—		—			—			—
Balance, March 31, 2011	25,084,734	$	251	$	178,417		$	1,255		$	179,923
	Common Stock			Additional Paid-in Capital			Cumulative Distributions in Excess of Net Income			Total Stockholders’ Equity
	Shares	Amounts
Balance, December 31, 2011	36,891,712	$	369	$	344,995		$	(18,791	)	$	326,573
Net income	—	—		—			4,405			4,405
Amortization of stock-based compensation	—	—		2,203			—			2,203
Stock issuance	117,890	1		(371		)	—			(370		)
Common dividends ($0.33 per share)	—	—		—			(12,213		)	(12,213		)
Balance, March 31, 2012	37,009,602	$	370	$	346,827		$	(26,599	)	$	320,598

See accompanying notes to condensed consolidated financial statements.

5

SABRA HEALTH CARE REIT, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

	Three Months Ended March 31,
	2012			2011
Cash flows from operating activities:
Net income	$	4,405		$	1,248
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	7,303			6,086
Amortization of deferred financing costs	566			495
Stock-based compensation expense	2,203			1,142
Amortization of premium on notes payable	(4		)	(4		)
Straight-line rental income adjustments	(969		)	—
Changes in operating assets and liabilities:
Prepaid expenses and other assets	(126		)	391
Accounts payable and accrued liabilities	4,053			4,106
Restricted cash	(967		)	(1,006		)
Net cash provided by operating activities	16,464			12,458
Cash flows from investing activities:
Acquisitions of real estate	(29,850		)	—
Origination of note receivable	(10,103		)	—
Acquisition of note receivable	—			(5,329		)
Additions to real estate	(256		)	(86		)
Net cash used in investing activities	(40,209		)	(5,415		)
Cash flows from financing activities:
Principal payments on mortgage notes payable	(791		)	(760		)
Payments of deferred financing costs	(2,456		)	(306		)
Payments related to the issuance of common stock	(370		)	—
Dividends paid	(12,213		)	—
Net cash used in financing activities	(15,830		)	(1,066		)
Net (decrease) increase in cash and cash equivalents	(39,575		)	5,977
Cash and cash equivalents, beginning of period	42,250			74,233
Cash and cash equivalents, end of period	$	2,675		$	80,210
Supplemental disclosure of cash flow information:
Interest paid	$	2,140		$	2,447

See accompanying notes to condensed consolidated financial statements.

6

SABRA HEALTH CARE REIT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1. BUSINESS

Overview

Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) was incorporated on May 10, 2010 as a wholly owned subsidiary of Sun Healthcare Group, Inc. (“Old Sun”) and commenced operations upon completion of the Separation and REIT Conversion Merger (discussed below) on November 15, 2010 (the “Separation Date”). Sabra is organized to qualify as a real estate investment trust (“REIT”) and will elect to be treated as a REIT for U.S. federal income tax purposes upon the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. Sabra’s primary business consists of acquiring, financing and owning real estate property to be leased to third party tenants in the healthcare sector. Sabra owns substantially all of its assets and properties and conducts its operations through Sabra Health Care Limited Partnership, a Delaware limited partnership (the “Operating Partnership”), of which Sabra is the sole general partner, or by subsidiaries of the Operating Partnership. As of March 31, 2012, Sabra’s investment portfolio included 99 properties (consisting of (i) 89 skilled nursing/post-acute facilities, (ii) nine senior housing facilities, and (iii) one acute care hospital). In addition, as of March 31, 2012, a wholly owned subsidiary of the Company was the lender under a loan (the "Mezzanine Loan") secured by the borrowers' equity interests in three skilled nursing facilities and one assisted living facility located in Texas and including a purchase option on these four facilities. The Mezzanine Loan was originated on March 15, 2012 for $10.0 million.

Separation and REIT Conversion Merger

On May 24, 2010, Old Sun announced its intention to restructure its business by separating its real estate assets and its operating assets into two separate publicly traded companies, Sabra and SHG Services Inc. (which has been renamed “Sun Healthcare Group, Inc.” or “Sun”). In order to effect the restructuring, Old Sun distributed to its stockholders on a pro rata basis all of the outstanding shares of common stock of Sun (this distribution is referred to as the “Separation”), together with an additional cash distribution. Immediately following the Separation, Old Sun merged with and into Sabra, with Sabra surviving the merger and Old Sun stockholders receiving shares of Sabra common stock in exchange for their shares of Old Sun common stock (this merger is referred to as the “REIT Conversion Merger”). Effective November 15, 2010, the Separation and REIT Conversion Merger were completed and Sabra and Sun began operations as separate companies.

Following the Separation, Sun, through its subsidiaries, continued the business and operations of Old Sun and its subsidiaries. Sabra did not operate prior to the Separation. Immediately following the Separation, subsidiaries of Sabra owned substantially all of Old Sun’s owned real property. The owned real property held by subsidiaries of Sabra following the Separation includes fixtures and certain personal property associated with the real property. The historical consolidated financial statements of Old Sun became the historical consolidated financial statements of Sun at the time of the Separation. At the time of the Separation, the balance sheet of Sabra included the owned real property and mortgage indebtedness to third parties on the real property as well as indebtedness incurred by Sabra prior to completion of the Separation. The statements of income and cash flows of Sabra consist solely of its operations after the Separation. The Separation was accounted for as a reverse spinoff. Accordingly, Sabra’s assets and liabilities are recorded at the historical carrying values of Old Sun.

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation and Basis of Presentation

The condensed consolidated financial statements include the accounts of Sabra and its wholly owned subsidiaries. All significant intercompany balances and transactions are eliminated in consolidation.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information as contained within the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and the rules and regulations of the Securities and Exchange Commission (the "SEC"), including the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for financial statements. In the opinion of management, the financial statements for the unaudited interim period presented include all adjustments, which are of a normal and recurring nature, necessary for a fair statement of the results for such period. Operating results for the three months ended March 31, 2012 are not necessarily indicative of the results that may be expected for the year ending December 31, 2012. For further information, refer to the Company’s consolidated financial statements and notes thereto for the year ended December 31, 2011 included in the Company’s 2011 Annual Report on

7

Form 10-K filed with the SEC.

Use of Estimates

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.

Real Estate Acquisition Valuation

The Company accounts for the acquisition of income-producing real estate or real estate that will be used for the production of income as a business combination. All assets acquired and liabilities assumed in a business combination are measured at their acquisition-date fair values. Acquisition pursuit costs are expensed as incurred and restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. During the three months ended March 31, 2012, the Company expensed $0.5 million of acquisition pursuit costs, which is included in general and administrative expense on the accompanying condensed consolidated statements of income.

Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property-operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income.

Interest Income

Interest income on the Company’s loan receivable is recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination costs are amortized over the term of the loan as an adjustment to interest income. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on nonaccrual status and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines the collection of interest according to the contractual terms of the loan is probable, the Company will resume the accrual of interest. On March 15, 2012, a wholly owned subsidiary of the Company entered into the Mezzanine Loan. The Mezzanine Loan has a five year term, bears interest at a fixed rate of 11.0% per annum and is secured by the borrowers' equity interests in three skilled nursing facilities and one assisted living facility located in Texas. The Company has an option to purchase the three skilled nursing facilities and one assisted living facility before March 31, 2013 for up to an aggregate purchase price of $43.0 million and increasing 2.5% for each of the two years thereafter. Upon exercise of the purchase option, the Company would expect to enter into a new 15 year triple-net master lease having 2 five-year renewal options.

3. ACQUISITIONS OF REAL ESTATE

During the three months ended March 31, 2012, the Company acquired two skilled nursing facilities for a total purchase price of $29.9 million. The purchase price was allocated as follows (in thousands):

				Intangibles
Land		Building and Improvements		Tenant Origination and Absorption Costs		Tenant Relationship		Total Purchase Price
$	5,100	$	24,150	$	500	$	100	$	29,850

As of March 31, 2012, the purchase price allocations for these properties are preliminary pending the receipt of information necessary to complete the valuation of certain tangible and intangible assets and liabilities and therefore are subject to change.

The tenant origination and absorption costs intangible assets and tenant relationship intangible assets acquired in connection with these acquisitions have weighted-average amortization periods as of the date of acquisition of 15 years and 25 years, respectively.

For the three months ended March 31, 2012, the Company recognized $18,000 of total revenues from these properties.

8

4. REAL ESTATE INVESTMENTS

The Company’s investments in real estate consisted of the following (dollars in thousands):

As of March 31, 2012

Property Type	Number of Properties	Number of Beds/Units	Total Real Estate at Cost		Accumulated Depreciation			Total Real Estate Investments, Net
Skilled Nursing/Post-Acute	89	10,154	$	687,473	$	(105,903	)	$	581,570
Senior Housing	9	773	47,449		(8,582		)	38,867
Acute Care Hospital	1	70	61,640		(1,616		)	60,024
	99	10,997	796,562		(116,101		)	680,461
Corporate Level			239		(65		)	174
			$	796,801	$	(116,166	)	$	680,635

As of December 31, 2011

Property Type	Number of Properties	Number of Beds/Units	Total Real Estate at Cost		Accumulated Depreciation			Total Real Estate Investments, Net
Skilled Nursing/Post-Acute	87	10,034	$	658,222	$	(99,570	)	$	558,652
Senior Housing	9	773	47,192		(8,140		)	39,052
Acute Care Hospital	1	70	61,640		(1,154		)	60,486
	97	10,877	767,054		(108,864		)	658,190
Corporate Level			239		(52		)	187
			$	767,293	$	(108,916	)	$	658,377

	March 31, 2012			December 31, 2011
Building and improvements	$	650,784		$	626,877
Furniture and equipment	44,546			44,045
Land improvements	4,640			4,640
Land	96,831			91,731
	796,801			767,293
Accumulated depreciation	(116,166		)	(108,916		)
	$	680,635		$	658,377

Operating Leases

All of the Company’s real estate properties are leased under triple-net operating leases with expirations ranging from 9 to 23 years. As of March 31, 2012, the leases have a weighted-average remaining term of 12 years. The leases include provisions to extend the lease terms and other negotiated terms and conditions. The Company, through its subsidiaries, retains substantially all of the risks and benefits of ownership of the real estate assets leased to the tenants. In addition, the Company may receive additional security under these operating leases in the form of security deposits from the lessee or guarantees from the parent of the lessee. As of March 31, 2012, 86 of the Company's 99 real estate properties were leased to subsidiaries of Sun. For further discussion of the Company’s tenant and revenue concentration, see “Note 11. Commitments and Contingencies—Concentration of Credit Risk.”

As of March 31, 2012, the future minimum rental income from the Company’s properties under non-cancelable operating leases is as follows (in thousands):

April 1, 2012 through December 31, 2012	$	73,536
2013	98,048
2014	98,048
2015	98,048
2016	98,048
Thereafter	676,676
	$	1,142,404

9

5. DEBT

Mortgage Indebtedness. The Company’s mortgage notes payable consist of the following (dollars in thousands):

Interest Rate Type	Principal Outstanding as of March 31, 2012 (2)		Principal Outstanding as of December 31, 2011 (2)		Weighted Average Interest Rate at March 31, 2012		Maturity Date
Fixed Rate	$	98,249	$	98,739	6.29	%	August 2015 - June 2047
Variable Rate(1)	58,858		59,159		5.50	%	August 2015
	$	157,107	$	157,898

^{(1)  Contractual interest rates under variable rate mortgages are equal to the 90-day LIBOR plus 4.5% (subject to a 1.0% LIBOR floor).} 

^{(2)  Outstanding principal balance for mortgage indebtedness does not include mortgage premium of $0.5 million as of March 31, 2012 and December 31, 2011.} 

8.125% Senior Notes due 2018. On October 27, 2010, the Operating Partnership and Sabra Capital Corporation, wholly owned subsidiaries of the Company (the “Issuers”), issued $225.0 million aggregate principal amount of senior, unsecured notes (the “Senior Notes”) in a private placement. The Senior Notes were sold at par, resulting in gross proceeds of $225.0 million and net proceeds of approximately $219.9 million after deducting commissions and expenses. On December 6, 2010, substantially all of the net proceeds were used by Sun to redeem the $200.0 million in aggregate principal amount outstanding of Old Sun’s 9.125% senior subordinated notes due 2015, including accrued and unpaid interest and the applicable redemption premium. In March 2011, the Issuers completed an exchange offer to exchange the Senior Notes for substantially identical 8.125% senior unsecured notes registered under the Securities Act of 1933, as amended (also referred to herein as the “Senior Notes”).

The obligations under the Senior Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by Sabra and certain of Sabra’s other existing and, subject to certain exceptions, future subsidiaries; provided, however, that such guarantees are subject to release under certain customary circumstances.  See "Note 9. Summarized Condensed Consolidating Information" for additional information concerning the circumstances pursuant to which the guarantors will be automatically and unconditionally released from their obligations under the guarantees.

The Senior Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, on or after November 1, 2014, at the redemption prices set forth in the indenture governing the Senior Notes (the “Indenture”), plus accrued and unpaid interest to the applicable redemption date. In addition, prior to November 1, 2014, the Issuers may redeem all or a portion of the Senior Notes at a redemption price equal to 100% of the principal amount of the Senior Notes redeemed, plus a “make-whole” premium, plus accrued and unpaid interest to the applicable redemption date. At any time, or from time to time, on or prior to November 1, 2013, the Issuers may redeem up to 35% of the principal amount of the Senior Notes, using the proceeds of specific kinds of equity offerings, at a redemption price of 108.125% of the principal amount to be redeemed, plus accrued and unpaid interest, if any, to the applicable redemption date. Assuming the Senior Notes are not redeemed, the Senior Notes mature on November 1, 2018.

The Indenture governing the Senior Notes contains restrictive covenants that, among other things, restrict the ability of Sabra, the Issuers and their restricted subsidiaries to: (i) incur or guarantee additional indebtedness; (ii) incur or guarantee secured indebtedness; (iii) pay dividends or distributions on, or redeem or repurchase, their capital stock; (iv) make certain investments or other restricted payments; (v) sell assets; (vi) create liens on their assets; (vii) enter into transactions with affiliates; (viii) merge or consolidate or sell all or substantially all of their assets; and (ix) create restrictions on the ability of Sabra and its restricted subsidiaries to pay dividends or other amounts to Sabra. The Indenture governing the Senior Notes also provides for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the Senior Notes, the failure to comply with certain covenants and agreements specified in the Indenture for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then outstanding Senior Notes may become due and payable immediately. As of March 31, 2012, the Company was in compliance with all applicable financial covenants under the Senior Notes.

Secured Revolving Credit Facility. On November 3, 2010, the Operating Partnership and certain subsidiaries of the Operating Partnership (together with the Operating Partnership, the “Borrowers”) entered into a secured revolving credit facility with certain lenders as set forth in the related credit agreement and Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer (each as defined in such credit agreement). The secured revolving credit facility is secured by, among other things, a first priority lien against certain of the properties owned by certain of the Company’s subsidiaries.

10

The obligations of the Borrowers under the secured revolving credit facility are guaranteed by the Company and certain of its subsidiaries. On February 10, 2012, the Borrowers amended the secured revolving credit facility (the “Amended Secured Revolving Credit Facility”) to increase the borrowing capacity from $100.0 million to $200.0 million (up to $20.0 million of which may be utilized for letters of credit) and to include an accordion feature that allows the Borrowers to increase borrowing availability under the Amended Secured Revolving Credit Facility by up to an additional $150.0 million, subject to certain terms and conditions. Borrowing availability under the Amended Secured Revolving Credit Facility is subject to a borrowing base calculation based on, among other factors, the lesser of (i) the mortgageability cash flow (as such term is defined in the credit agreement ) or (ii) the appraised value, in each case of the properties securing the Amended Secured Revolving Credit Facility. The entire $200.0 million was available for borrowing under the Amended Secured Revolving Credit Facility as of March 31, 2012. Borrowing availability under the Amended Secured Revolving Credit Facility terminates, and all borrowings mature, on February 10, 2015, subject to a one-year extension option. As of March 31, 2012, there were no amounts outstanding on the Company’s Amended Secured Revolving Credit Facility.

Borrowings under the Amended Secured Revolving Credit Facility bear interest on the outstanding principal amount at a rate equal to an applicable percentage plus, at the Borrowers' option, either (a) LIBOR or (b) a base rate determined as the greater of (i) the federal funds rate plus 0.5%, (ii) the prime rate, and (iii) one-month LIBOR plus 1.0% (the “Base Rate”). The applicable percentage for borrowings will vary based on the Consolidated Leverage Ratio, as defined in the amended credit agreement, and will range from 2.00% to 3.00% per annum for borrowings at the Base Rate and 3.00% to 4.00% per annum for LIBOR based borrowings. In addition, the Borrowers are required to pay a facility fee to the lenders equal to between 0.35% and 0.50% per annum based on the amount of unused borrowings under the Amended Secured Revolving Credit Facility. During the three months ended March 31, 2012, the Company incurred $0.2 million of unused facility fees.

The Amended Secured Revolving Credit Facility contains customary covenants that include restrictions on the ability to make acquisitions and other investments, pay dividends, incur additional indebtedness, engage in non-healthcare related business activities, enter into transactions with affiliates and sell or otherwise transfer certain assets as well as customary events of default. The Amended Secured Revolving Credit Facility also requires the Company, through the Borrowers, to comply with specified financial covenants, which include a maximum leverage ratio, a minimum fixed charge coverage ratio and a minimum tangible net worth requirement. As of March 31, 2012, the Company was in compliance with all applicable financial covenants under the Amended Secured Revolving Credit Facility.

During the three months ended March 31, 2012 and 2011, the Company incurred interest expense of $7.7 million and $7.6 million, respectively. Included in interest expense for the three months ended March 31, 2012 and 2011, was $0.6 million and $0.5 million, respectively, of deferred financing costs amortization. As of March 31, 2012 and December 31, 2011, the Company had $8.4 million and $4.0 million, respectively, of accrued interest included in accounts payable and accrued liabilities on the accompanying condensed consolidated balance sheets.

The following is a schedule of maturities for the Company’s outstanding debt as of March 31, 2012 (in thousands):

	Mortgage Indebtedness  (1)		Senior Notes		Amended Secured Revolving Credit Facility		Total
April 1, 2012 through December 31, 2012	$	2,413	$	—	$	—	$	2,413
2013	3,428		—		—		3,428
2014	3,649		—		—		3,649
2015	86,048		—		—		86,048
2016	1,689		—		—		1,689
Thereafter	59,880		225,000		—		284,880
	$	157,107	$	225,000	$	—	$	382,107

⁽¹⁾  Outstanding principal balance for mortgage indebtedness does not include mortgage premium of $0.5 million as of March 31, 2012.

6.FAIR VALUE DISCLOSURES

The fair value for certain financial instruments is derived using a combination of market quotes, pricing models and other valuation techniques that involve significant management judgment. The price transparency of financial instruments is a key determinant of the degree of judgment involved in determining the fair value of the Company’s financial instruments.

Financial instruments for which actively quoted prices or pricing parameters are available and whose markets contain orderly transactions will generally have a higher degree of price transparency than financial instruments whose markets are inactive or consist of non-orderly trades. The Company evaluates several factors when determining if a market is inactive or

11

when market transactions are not orderly. The carrying values of cash and cash equivalents, restricted cash, accounts payable and accrued liabilities are reasonable estimates of fair value because of the short-term maturities of these instruments. Fair values for other financial instruments are derived as follows:

Mezzanine Loan: This instrument is presented in the accompanying condensed consolidated balance sheets at its amortized cost and not at fair value. The fair value of the Mezzanine Loan was estimated using an internal valuation model that considered the expected cash flows for the Mezzanine Loan, the underlying collateral value and other credit enhancements.

Senior Notes: The fair values of the Senior Notes were determined using third-party market quotes derived from orderly trades.

Mortgage indebtedness: The fair values of the Company’s notes payable were estimated using a discounted cash flow analysis based on management’s estimates of current market interest rates for instruments with similar characteristics, including remaining loan term, loan-to-value ratio, type of collateral and other credit enhancements.

The following are the carrying amounts and fair values of the Company’s financial instruments as of March 31, 2012 and December 31, 2011 whose carrying amounts do not approximate their fair value:

	March 31, 2012						December 31, 2011
	Face Value (1)		Carrying Amount (2)		Fair Value		Face Value (1)		Carrying Amount (2)		Fair Value
Financial assets:
Mezzanine Loan	$	10,000	$	10,128	$	10,000	$	—	$	—	$	—
Financial liabilities:
Senior Notes	225,000		225,000		237,938		225,000		225,000		227,813
Mortgage indebtedness	157,107		157,603		171,583		157,898		158,398		172,829

⁽¹⁾ Face value represents amounts contractually due under the terms of the respective agreements.

⁽²⁾ Carrying amounts represent the book value of financial instruments and include unamortized premiums (discounts).

The Company determined the fair value of financial instruments as of March 31, 2012 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands):

			Fair Value Measurements Using
			Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
Financial assets:
Mezzanine Loan	$	10,000	$	—	$	—	$	10,000
Financial liabilities:
Senior Notes	$	237,938	$	—	$	237,938	$	—
Mortgage indebtedness	$	171,583	$	—	$	—	$	171,583

Disclosure of the fair value of financial instruments is based on pertinent information available to the Company at the applicable dates and requires a significant amount of judgment. Despite increased capital market and credit market activity, transaction volume for certain financial instruments remains relatively low. This has made the estimation of fair values difficult and, therefore, both the actual results and the Company’s estimate of fair value at a future date could be materially different.

During the three months ended March 31, 2012, the Company measured the following assets at fair value with valuation methods utilizing the following types of inputs (in thousands):

			Fair Value Measurements Using
			Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
Nonrecurring Basis:
Investments in real estate (1)	$	29,850	$	—	$	—	$	29,850

⁽¹⁾ Amount reflects acquisition date fair value of real estate acquired in 2012.

12

The significant unobservable inputs used in the measurement of the Company's real estate acquisition date fair value include comparable transaction prices for similar properties, market lease rates, discount rates and lease-up periods. Significant increases or decreases in any of these inputs in isolation would result in a significantly different fair value measurement.

7. EQUITY

Common Stock

The following table lists the cash dividends on common stock declared and paid by the Company during the three months ended March 31, 2012:

Declaration Date	Record Date	Amount Per Share		Dividend Payable Date
February 29, 2012	March 15, 2012	$	0.33	March 30, 2012

On April 24, 2012, the Company announced that its board of directors declared a quarterly cash dividend of $0.33 per share of common stock. The dividend will be paid on May 31, 2012 to stockholders of record as of the close of business on May 15, 2012.

On August 1, 2011, the Company completed an underwritten public offering of 11.7 million newly issued shares of its common stock pursuant to a registration statement filed with the SEC, which became effective on July 26, 2011.  The Company received net proceeds, before expenses, of $163.9 million from the offering, after giving effect to the issuance and sale of all 11.7 million shares of common stock (which included 1.5 million shares sold to the underwriters upon exercise of their option to purchase additional shares to cover over-allotments), at a price to the public of $14.75 per share.

During the three months ended March 31, 2012, the Company issued 117,890 shares of common stock as a result of restricted stock unit vestings and in connection with incentive bonus payments payable under the Company's 2011 Bonus Plan pursuant to an election to receive the bonus payment in shares of the Company's common stock.

8. EARNINGS PER COMMON SHARE

The following table illustrates the computation of basic and diluted earnings per share for the three months ended March 31, 2012 and 2011 (in thousands, except share and per share amounts):

	Three Months Ended March 31,
	2012		2011
Numerator
Net income	$	4,405	$	1,248
Denominator
Basic weighted average common shares	37,035,970		25,136,140
Dilutive stock options and restricted stock units	22,916		75,445
Diluted weighted average common shares	37,058,886		25,211,585
Basic earnings per common share	$	0.12	$	0.05
Diluted earnings per common share	$	0.12	$	0.05

Restricted stock and certain of the Company’s performance restricted stock units are considered participating securities which require the use of the two-class method when computing basic and diluted earnings per share. During the three months ended March 31, 2012 and 2011, approximately 0.2 million and 0.5 million restricted stock units, respectively, and options to purchase approximately 0.4 million shares were not included because they were anti-dilutive.

13

9.SUMMARIZED CONDENSED CONSOLIDATING INFORMATION

In connection with the offering of the Senior Notes by the Issuers in October 2010, the Company and certain 100% owned subsidiaries of the Company (the “Guarantors”) have, jointly and severally, fully and unconditionally guaranteed the Senior Notes, subject to release under certain customary circumstances as described below. These guarantees are subordinated to all existing and future senior debt and senior guarantees of the Guarantors and are unsecured. The Company conducts all of its business through and derives virtually all of its income from its subsidiaries. Therefore, the Company’s ability to make required payments with respect to its indebtedness (including the Senior Notes) and other obligations depends on the financial results and condition of its subsidiaries and its ability to receive funds from its subsidiaries.

A Guarantor will be automatically and unconditionally released from its obligations under the guarantees with respect to the Senior Notes in the event of:

• Any sale of the subsidiary Guarantor or of all or substantially all of its assets;

• A merger or consolidation of a subsidiary Guarantor with an issuer of the Senior Notes or another Guarantor, provided that the surviving entity remains a Guarantor;

• A subsidiary Guarantor is declared "unrestricted" for covenant purposes under the Indenture;

• The requirements for legal defeasance or covenant defeasance or to discharge the Indenture have been satisfied;

• A liquidation or dissolution, to the extent permitted under the Indenture, of a subsidiary Guarantor; and

• The release or discharge of the guaranty that resulted in the creation of the subsidiary guaranty, except a discharge or release by or as a result of payment under such guaranty.

Pursuant to Rule 3-10 of Regulation S-X, the following summarized consolidating information is provided for the Company (the “Parent Company”), the Issuers, the Guarantors, and the Company’s non-Guarantor subsidiaries with respect to the Senior Notes. This summarized financial information has been prepared from the books and records maintained by the Company, the Issuers, the Guarantors and the non-Guarantor subsidiaries. The summarized financial information may not necessarily be indicative of the results of operations or financial position had the Issuers, the Guarantors or non-Guarantor subsidiaries operated as independent entities. Sabra’s investments in its consolidated subsidiaries are presented based upon Sabra's proportionate share of each subsidiary's net assets. The Guarantor subsidiaries’ investments in the non-Guarantor subsidiaries and non-Guarantor subsidiaries’ investments in Guarantor subsidiaries are presented under the equity method of accounting. Intercompany activities between subsidiaries and the Parent Company are presented within operating activities on the condensed consolidating statement of cash flows.

Condensed consolidating financial statements for the Company and its subsidiaries, including the Parent Company only, the Issuers, the combined Guarantor subsidiaries and the combined non-Guarantor subsidiaries, are as follows:

14

CONDENSED CONSOLIDATING BALANCE SHEET

March 31, 2012

(in thousands, except share and per share amounts)

(unaudited)

	Parent Company			Issuers		Combined Guarantor Subsidiaries		Combined  Non- Guarantor Subsidiaries		Elimination			Consolidated
Assets
Real estate investments, net of accumulated depreciation	$	175		$	—	$	498,583	$	181,877	$	—		$	680,635
Cash and cash equivalents	1,634			—		—		1,041		—			2,675
Restricted cash	—			—		—		6,664		—			6,664
Deferred tax assets	25,540			—		—		—		—			25,540
Prepaid expenses, deferred financing costs and other assets	995			4,893		22,211		2,932		—			31,031
Intercompany	1,049			145,017		—		27,634		(173,700		)	—
Investment in subsidiaries	322,261			404,968		24,195		—		(751,424		)	—
Total assets	$	351,654		$	554,878	$	544,989	$	220,148	$	(925,124	)	$	746,545
Liabilities and stockholders’ equity
Mortgage notes payable	$	—		$	—	$	—	$	157,603	$	—		$	157,603
Senior unsecured notes payable	—			225,000		—		—		—			225,000
Accounts payable and accrued liabilities	5,516			7,617		3,805		866		—			17,804
Tax liability	25,540			—		—		—		—			25,540
Intercompany	—			—		173,700		—		(173,700		)	—
Total liabilities	31,056			232,617		177,505		158,469		(173,700		)	425,947
Stockholders’ equity:
Preferred stock, $.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of March 31, 2012	—			—		—		—		—			—
Common stock, $.01 par value; 125,000,000 shares authorized, 37,009,602 shares issued and outstanding as of March 31, 2012	370			—		—		—		—			370
Additional paid-in capital	346,827			289,452		316,978		52,313		(658,743		)	346,827
Cumulative distributions in excess of net income	(26,599		)	32,809		50,506		9,366		(92,681		)	(26,599		)
Total stockholders’ equity	320,598			322,261		367,484		61,679		(751,424		)	320,598
Total liabilities and stockholders’ equity	$	351,654		$	554,878	$	544,989	$	220,148	$	(925,124	)	$	746,545

15

CONDENSED CONSOLIDATING BALANCE SHEET

December 31, 2011

(in thousands, except share and per share amounts)

	Parent Company			Issuers		Combined Guarantor Subsidiaries		Combined  Non- Guarantor Subsidiaries		Elimination			Consolidated
Assets
Real estate investments, net of accumulated depreciation	$	187		$	—	$	474,256	$	183,934	$	—		$	658,377
Cash and cash equivalents	41,736			—		—		514		—			42,250
Restricted cash	—			—		—		6,093		—			6,093
Deferred tax assets	25,540			—		—		—		—			25,540
Prepaid expenses, deferred financing costs and other assets	874			5,079		8,544		2,893		—			17,390
Intercompany	—			145,018		—		25,237		(170,255		)	—
Investment in subsidiaries	313,181			391,131		23,611		—		(727,923		)	—
Total assets	$	381,518		$	541,228	$	506,411	$	218,671	$	(898,178	)	$	749,650
Liabilities and stockholders’ equity
Mortgage notes payable	$	—		$	—	$	—	$	158,398	$	—		$	158,398
Senior unsecured notes payable	—			225,000		—		—		—			225,000
Accounts payable and accrued liabilities	6,296			3,047		4,107		689		—			14,139
Tax liability	25,540			—		—		—		—			25,540
Intercompany	23,109			—		147,146		—		(170,255		)	—
Total liabilities	54,945			228,047		151,253		159,087		(170,255		)	423,077
Stockholders’ equity:
Preferred stock, $.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of December 31, 2011	—			—		—		—		—			—
Common stock, $.01 par value; 125,000,000 shares authorized, 36,891,712 shares issued and outstanding as of December 31, 2011	369			—		—		—		—			369
Additional paid-in capital	344,995			288,665		316,011		52,110		(656,786		)	344,995
Cumulative distributions in excess of net income	(18,791		)	24,516		39,147		7,474		(71,137		)	(18,791		)
Total stockholders’ equity	326,573			313,181		355,158		59,584		(727,923		)	326,573
Total liabilities and stockholders’ equity	$	381,518		$	541,228	$	506,411	$	218,671	$	(898,178	)	$	749,650

16

CONDENSED CONSOLIDATING STATEMENT OF INCOME

For the Three Months EndedMarch 31, 2012

(in thousands, except share and per share amounts)

(unaudited)

	Parent Company			Issuers			Combined Guarantor Subsidiaries			Combined  Non- Guarantor Subsidiaries		Elimination			Consolidated
Revenues:
Rental income	$	—		$	—		$	17,215		$	6,448	$	—		$	23,663
Interest income	6			—			58			—		—			64
Total revenues	6			—			17,273			6,448		—			23,727
Expenses:
Depreciation and amortization	12			—			5,232			2,059		—			7,303
Interest	—			4,757			463			2,478		—			7,698
General and administrative	3,882			—			419			20		—			4,321
Income in subsidiary	(8,293		)	(13,050		)	(202		)	—		21,545			—
Total expenses	(4,399		)	(8,293		)	5,912			4,557		21,545			19,322
Net income	$	4,405		$	8,293		$	11,361		$	1,891	$	(21,545	)	$	4,405
Net income per common share, basic															$	0.12
Net income per common share, diluted															$	0.12
Weighted-average number of common shares outstanding, basic															37,035,970
Weighted-average number of common shares outstanding, diluted															37,058,886

17

CONDENSED CONSOLIDATING STATEMENT OF INCOME

For the Three Months Ended March 31, 2011

(in thousands, except share and per share amounts)

(unaudited)

	Parent Company			Issuers			Combined Guarantor Subsidiaries			Combined  Non- Guarantor Subsidiaries		Elimination			Consolidated
Revenues:
Rental income	$	—		$	—		$	11,270		$	6,291	$	—		$	17,561
Interest income	28			—			12			—		—			40
Total revenues	28			—			11,282			6,291		—			17,601
Expenses:
Depreciation and amortization	15			—			3,939			2,132		—			6,086
Interest	—			4,749			322			2,526		—			7,597
General and administrative	2,631			—			2			37		—			2,670
Income in subsidiary	(3,866		)	(8,615		)	(94		)	—		12,575			—
Total expenses	(1,220		)	(3,866		)	4,169			4,695		12,575			16,353
Net income	$	1,248		$	3,866		$	7,113		$	1,596	$	(12,575	)	$	1,248
Net income per common share, basic															$	0.05
Net income per common share, diluted															$	0.05
Weighted-average number of common shares outstanding, basic															25,136,140
Weighted-average number of common shares outstanding, diluted															25,211,585

18

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the Three Months Ended March 31, 2012

(in thousands)

(unaudited)

	Parent Company			Issuers		Combined Guarantor Subsidiaries			Combined  Non- Guarantor Subsidiaries			Elimination			Consolidated
Net cash provided by operating activities	$	15,369		$	—	$	—		$	1,095		$	—		$	16,464
Cash flows from investing activities:
Acquisitions of real estate	—			—		(29,850		)	—			—			(29,850		)
Origination of note receivable	—			—		(10,103		)	—			—			(10,103		)
Additions to real estate	—			—		(256		)	—			—			(256		)
Investment in Subsidiary	(728		)									728			—
Net cash used in investing activities	(728		)	—		(40,209		)	—			728			(40,209		)
Cash flows from financing activities:
Principal payments on mortgage notes payable	—			—		—			(791		)	—			(791		)
Payments of deferred financing costs	—			—		(2,296		)	(160		)	—			(2,456		)
Payments related to the issuance of common stock	(370		)	—		—			—			—			(370		)
Dividends paid	(12,213		)	—		—			—			—			(12,213		)
Contribution from Parent	—			—		—			728			(728		)	—
Distribution to Parent	—			—		—			(345		)	345			—
Distribution from Subsidiary	345			—		—			—			(345		)	—
Intercompany financing	(42,505		)	—		42,505			—			—			—
Net cash provided by (used in) financing activities	(54,743		)	—		40,209			(568		)	(728		)	(15,830		)
Net decrease in cash and cash equivalents	(40,102		)	—		—			527			—			(39,575		)
Cash and cash equivalents, beginning of period	41,736			—		—			514			—			42,250
Cash and cash equivalents, end of period	$	1,634		$	—	$	—		$	1,041		$	—		$	2,675

19

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the Three Months Ended March 31, 2011

(in thousands)

(unaudited)

	Parent Company			Issuers		Combined Guarantor Subsidiaries		Combined  Non- Guarantor Subsidiaries			Elimination		Consolidated
Net cash provided by operating activities	$	8,038		$	—	$	—	$	4,420		$	—	$	12,458
Cash flows from investing activities:
Acquisition of note receivable	(5,329		)	—		—		—			—		(5,329		)
Additions to real estate	(86		)	—		—		—			—		(86		)
Net cash used in investing activities	(5,415		)	—		—		—			—		(5,415		)
Cash flows from financing activities:
Principal payments on mortgage notes payable	—			—		—		(760		)	—		(760		)
Payments of deferred financing costs	(306		)	—		—		—			—		(306		)
Intercompany financing	3,636			—		—		(3,636		)	—		—
Net cash provided by (used in) financing activities	3,330			—		—		(4,396		)	—		(1,066		)
Net decrease in cash and cash equivalents	5,953			—		—		24			—		5,977
Cash and cash equivalents, beginning of period	70,841			—		—		3,392			—		74,233
Cash and cash equivalents, end of period	$	76,794		$	—	$	—	$	3,416		$	—	$	80,210

20

10. PRO FORMA FINANCIAL INFORMATION

The following table summarizes, on an unaudited pro forma basis, the combined results of operations of the Company for the three months ended March 31, 2012 and 2011. The Company acquired two properties and originated the Mezzanine Loan during the three months ended March 31, 2012. The following unaudited pro forma information for the three months ended March 31, 2012 and 2011 has been prepared to give effect to these transactions and for the eleven acquisitions that occurred during 2011, as well as the offering of 11.7 million shares of common stock that closed in August 2011, as if they had occurred on January 1, 2011. This pro forma information does not purport to represent what the actual results of operations of the Company would have been had these acquisitions occurred on this date, nor does it purport to predict the results of operations for future periods (in thousands, except share and per share amounts):

	Three Months Ended March 31,
	2012		2011
Revenues	$	24,775	$	24,102
Depreciation and amortization	7,488		7,738
Net income	5,703		6,097
Net income per common share, basic	0.15		0.17
Net income per common share, diluted	0.15		0.17
Weighted-average number of common shares outstanding, basic	37,035,970		36,866,140
Weighted-average number of common shares outstanding, diluted	37,058,886		36,941,585

11.COMMITMENTS AND CONTINGENCIES

Concentration of Credit Risk

Concentrations of credit risks arise when a number of operators, tenants or obligors related to the Company’s investments are engaged in similar business activities, or activities in the same geographic region, or have similar economic features that would cause their ability to meet contractual obligations, including those to the Company, to be similarly affected by changes in economic conditions. The Company regularly monitors its portfolio to assess potential concentrations of risks.

Sun

As of March 31, 2012, 86 of the Company’s 99 real estate properties were leased to subsidiaries of Sun. During the three months ended March 31, 2012, 76% of the Company’s total revenues were derived from these leases. Sun is a publicly traded company and is subject to the informational filing requirements of the Securities Exchange Act of 1934, as amended, and is required to file periodic reports on Form 10-K and Form 10-Q with the SEC. As of March 31, 2012, Sun's continuing operations, through its subsidiaries, operated 190 inpatient centers spread across 23 states. Sun’s net revenues and adjusted earnings before interest, depreciation, amortization, restructuring costs and rent were $458.5 million and $52.3 million, respectively, for the three months ended March 31, 2012 and $466.3 million and $64.5 million, respectively, for the three months ended March 31, 2011. As of March 31, 2012, Sun’s outstanding debt, net of cash, totaled $44.7 million. As of March 31, 2012, Sun had approximately $104.8 million in liquidity, consisting of unrestricted cash and cash equivalents of $44.8 million and available borrowings of $60.0 million under Sun's revolving credit facility.

Cadia Portfolio

On August 1, 2011, the Company closed the purchase of four skilled nursing facilities (the “Cadia Portfolio”). The four skilled nursing facilities are located in Delaware, range in age from 2 to 15 years and have a combined total of 500 beds. In connection with the acquisition, the Company, through an indirect wholly owned subsidiary, entered into a new 15-year triple-net master lease agreement with the sellers (collectively, the “Cadia Tenants”). None of the Cadia Tenants are affiliated with the Company or any of its subsidiaries. As of March 31, 2012, the Company's investment in the Cadia Portfolio totaled 13% of the Company's assets, and during the three months ended March 31, 2012, 11% of the Company's total revenues were derived from the Cadia Portfolio lease. The Company believes that the financial condition and results of operations of the Cadia Tenants are more relevant to the Company’s investors than the financial statements of the Cadia Portfolio and enable investors to evaluate the credit-worthiness of the Cadia Tenants in their capacity as the tenants under the Cadia Portfolio lease. As a result, the Company has presented below unaudited summary financial information of the combined Cadia Tenants as of and for the three months ended March 31, 2012. The summary financial information presented below has been provided by the Cadia Tenants and has not been independently verified by the Company. The Company has no reason to believe that such information is inaccurate in any material respect.

21

	Three Months Ended March 31, 2012 (unaudited) (in thousands)
Statements of Operations
Revenues	$	14,959
Operating expenses	14,217
Net income	554
	As of March 31, 2012 (unaudited) (in thousands)
Balance Sheets
Cash and cash equivalents	$	5,950
Total current assets	10,614
Total current liabilities	7,132
Total debt	—

Other than the Company’s tenant concentrations, management believes the Company's current portfolio is reasonably diversified across healthcare related real estate and geographical location and does not contain any other significant concentration of credit risks. The Company’s portfolio of 99 real estate properties is diversified by location across 24 states. The properties in any one state did not account for more than 14% and 19%, respectively, of the Company’s total revenue during the three months ended March 31, 2012 and 2011.

Environmental

As an owner of real estate, the Company is subject to various environmental laws of federal, state and local governments. The Company is not aware of any environmental liability that could have a material adverse effect on its financial condition or results of operations. However, changes in applicable environmental laws and regulations, the uses and conditions of properties in the vicinity of the Company’s properties, the activities of its tenants and other environmental conditions of which the Company is unaware with respect to the properties could result in future environmental liabilities. Compliance with existing environmental laws is not expected to have a material adverse effect on the Company’s financial condition and results of operations as of March 31, 2012.

Indemnification Agreement

In connection with the Separation and REIT Conversion Merger, any liability arising from or relating to legal proceedings involving the Company’s real estate investments has been assumed by the Company and the Company will indemnify Sun (and its subsidiaries, directors, officers, employees and agents and certain other related parties) against any losses arising from or relating to such legal proceedings. In addition, pursuant to a distribution agreement entered into among Old Sun, the Company and Sun in connection with the Separation and REIT Conversion Merger, Sun has agreed to indemnify the Company (and the Company's subsidiaries, directors, officers, employees and agents and certain other related parties) for any liability arising from or relating to legal proceedings involving Old Sun’s healthcare business prior to the Separation, and, pursuant to the lease agreements between the Company and subsidiaries of Sun, the tenants agree to indemnify the Company for any liability arising from operations at the real property leased from the Company.

Immediately prior to the Separation, Old Sun was a party to various legal actions and administrative proceedings, including various claims arising in the ordinary course of its healthcare business, which are subject to the indemnities to be provided by Sun to the Company. While these actions and proceedings are not believed to be material, individually or in the aggregate, the ultimate outcome of these matters cannot be predicted. The resolution of any such legal proceedings, either individually or in the aggregate, could have a material adverse effect on Sun’s business, financial position or results of operations, which, in turn, could have a material adverse effect on the Company's business, financial position or results of operations if Sun or its subsidiaries are unable to meet their indemnification obligations.

Legal Matters

From time to time, the Company is party to legal proceedings that arise in the ordinary course of its business. Management is not aware of any legal proceedings where the likelihood of a loss contingency is reasonably possible and the amount or range of reasonably possible losses is material to the Company's results of operations, financial condition or cash flows.

22

12. SUBSEQUENT EVENTS

The Company evaluates subsequent events up until the date the condensed consolidated financial statements are issued.

Dividend Declaration

On April 24, 2012, the Company’s board of directors declared a quarterly cash dividend of $0.33 per share of common stock. The dividend will be paid on May 31, 2012 to stockholders of record as of May 15, 2012.

23

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The discussion below contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those which are discussed in the “Risk Factors” section in Part I, Item 1A of our 2011 Annual Report on Form 10-K. Also see “Statement Regarding Forward-Looking Statements” preceding Part I.

The following discussion and analysis should be read in conjunction with our accompanying condensed consolidated financial statements and the notes thereto.

Our Management’s Discussion and Analysis of Financial Condition and Results of Operations is organized as follows:

• Overview

• Recent Transactions

• Critical Accounting Policies

• Results of Operations

• Liquidity and Capital Resources

• Change in Skilled Nursing Facility Reimbursement Rates

• Obligations and Commitments

• Off-Balance Sheet Arrangements

Overview

We were incorporated on May 10, 2010 as a wholly owned subsidiary of Sun Healthcare Group, Inc. (“Old Sun”), a provider of nursing, rehabilitative and related specialty healthcare services principally to the senior population in the United States. Pursuant to a restructuring plan by Old Sun, Old Sun restructured its business by separating its real estate assets and its operating assets into two separate publicly traded companies, Sabra and SHG Services Inc. (which has been renamed “Sun Healthcare Group, Inc.” or “Sun”). In order to effect the restructuring, Old Sun distributed to its stockholders on a pro rata basis all of the outstanding shares of common stock of Sun (this distribution is referred to as the “Separation”), together with an additional cash distribution. Immediately following the Separation, Old Sun merged with and into Sabra, with Sabra surviving the merger and Old Sun stockholders receiving shares of Sabra common stock in exchange for their shares of Old Sun common stock (this merger is referred to as the “REIT Conversion Merger”). The Separation and REIT Conversion Merger were completed on November 15, 2010, which we refer to as the Separation Date.

Following the restructuring of Old Sun’s business and the completion of the Separation and REIT Conversion Merger, we became a self-administered, self-managed real estate investment trust (“REIT”) that, directly or indirectly, owns and invests in real estate serving the healthcare industry.

As of March 31, 2012, our investment portfolio included 99 real estate properties (consisting of (i) 89 skilled nursing/post-acute facilities, (ii) nine senior housing facilities, and (iii) one acute care hospital) and a mezzanine loan secured by the borrowers' equity interests in three skilled nursing facilities and one assisted living facility located in Texas and including a purchase option on these four facilities. As of March 31, 2012, our real estate properties had a total of 10,997 licensed beds, or units, spread across 24 states. As of March 31, 2012, all of our real estate properties are leased under triple-net operating leases with expirations ranging from 9 to 23 years.

We expect to continue to grow our portfolio primarily through the acquisition of healthcare facilities, including skilled nursing facilities, senior housing facilities (which may include assisted living, independent living and continuing care retirement community facilities) and hospitals, and through the origination of financing secured directly or indirectly by healthcare facilities. We intend to finance our investments with cash on hand and availability under our Amended Secured Revolving Credit Facility (as defined below). As we acquire additional properties and expand our portfolio, we expect to further diversify by tenant, asset class and geography within the healthcare sector. We employ a disciplined, opportunistic approach in our healthcare real estate investment strategy by investing in assets that provide attractive opportunities for dividend growth and appreciation of asset values, while maintaining balance sheet strength and liquidity, thereby creating long-term stockholder value.

We are organized to qualify as a REIT and we will elect to be treated as a REIT for U.S. federal income tax purposes upon the filing of our U.S. federal income tax return for the taxable year beginning January 1, 2011. We operate through an umbrella partnership (commonly referred to as an UPREIT) structure in which substantially all of our properties and assets are held by Sabra Health Care Limited Partnership, a Delaware limited partnership (the "Operating Partnership"), of which we are the sole general partner, or by subsidiaries of the Operating Partnership.

24

Recent Transactions

Pennsylvania Subacute Portfolio Acquisition

On March 30, 2012, we closed the purchase of two specialized skilled nursing facilities (the "Pennsylvania Subacute Portfolio") in a sale-leaseback transaction with affiliates of the sellers for $29.9 million. Each facility has 60 licensed beds and one facility was most recently renovated in 1990, while the other facility was most recently renovated in 2008. In connection with the acquisition, we, through an indirect wholly owned subsidiary, entered into a single 15-year triple-net master lease agreement with the sellers with two five-year renewal options. The Pennsylvania Subacute Portfolio lease provides for annual rent escalators equal to the greater of the change in the Consumer Price Index or 2.5%, resulting in annual lease revenues determined in accordance with GAAP of $3.4 million and an initial yield on cash rent of 9.50%. The purchase price was funded with available cash.

Meridian Mezzanine Loan

On March 15, 2012, we entered into a $10.0 million mezzanine loan agreement ("Mezzanine Loan") with affiliates of Meridian Equity Investors, L.P. (the "Meridian Borrowers"), with an option to purchase three skilled nursing facilities and one assisted living facility located in Texas and owned by the Meridian Borrowers (the "Meridian Facilities") before March 31, 2013 for up to an aggregate purchase price of $43.0 million and increasing by 2.5% for each of the two years thereafter. The Mezzanine Loan is secured by the Meridian Borrowers' equity interests in four entities that own and operate the Meridian Facilities. The Mezzanine Loan has a five year term and bears interest at a fixed rate of 11.0% per annum. Upon exercise of the purchase option, we would expect to enter into a new 15 year triple-net master lease having 2 five-year renewal options at an initial cash yield of the greater of 9.25% or fair market rent as determined at the start of the lease. The facilities range in age from 9 to 17 years and have a total of 394 licensed beds.

Amended Secured Revolving Credit Facility

On February 10, 2012, the Operating Partnership and certain subsidiaries of the Operating Partnership (together with the Operating Partnership, the “Borrowers”) amended the secured revolving credit facility (as amended, the “Amended Secured Revolving Credit Facility”) to increase the borrowing capacity from $100.0 million to $200.0 million (up to $20.0 million of which may be utilized for letters of credit) and to include an accordion feature that allows the Borrowers to increase borrowing availability under the Amended Secured Revolving Credit Facility by up to an additional $150.0 million, subject to certain terms and conditions. Borrowings under the Amended Secured Revolving Credit Facility bear interest on the outstanding principal amount at a rate equal to an applicable percentage plus, at the Borrowers' option, either (a) LIBOR or (b) a base rate determined as the greater of (i) the federal funds rate plus 0.5%, (ii) the prime rate, and (iii) one-month LIBOR plus 1.0% (the “Base Rate”). The applicable percentage for borrowings will vary based on the Consolidated Leverage Ratio, as defined in the credit agreement, and will range from 2.00% to 3.00% per annum for borrowings at the Base Rate and 3.00% to 4.00% per annum for LIBOR-based borrowings. See "—Liquidity and Capital Resources" for further information. In addition, the Borrowers are required to pay a facility fee to the lenders equal to between 0.35% and 0.50% per annum based on the amount of unused borrowings under the Amended Secured Revolving Credit Facility.

Critical Accounting Policies

Our consolidated interim financial statements have been prepared in accordance with GAAP and in conjunction with the rules and regulations of the SEC. The preparation of our financial statements requires significant management judgments, assumptions and estimates about matters that are inherently uncertain. These judgments affect the reported amounts of assets and liabilities and our disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. With different estimates or assumptions, materially different amounts could be reported in our financial statements. Additionally, other companies may utilize different estimates that may impact the comparability of our results of operations to those of companies in similar businesses. A discussion of the accounting policies that management considers critical in that they involve significant management judgments, assumptions and estimates is included in our 2011 Annual Report on Form 10-K filed with the SEC. There have been no significant changes to our critical accounting policies during the three months ended March 31, 2012.

Results of Operations

As of March 31, 2011, our investment portfolio included 86 real estate properties and an investment in a mortgage note, which was subsequently repaid. As of March 31, 2012, our investment portfolio included 99 real estate properties and an investment in a mezzanine loan. In general, we expect that our income and expenses related to our portfolio will increase in future periods as a result of owning investments acquired in 2011 for an entire period and the anticipated future acquisition of additional investments. The results of operations presented for the three months ended March 31, 2012 and 2011 are not directly comparable due to the increase in acquisition activity subsequent to March 31, 2011.

25

Comparison of the three months ended March 31, 2012 versus the three months ended March 31, 2011 (dollars in thousands):

	Three Months Ended March 31,				Increase		Percentage Difference		Increase due to Acquisitions (1)		Increase (Decrease) Due to Properties Held Throughout Both Periods (2)
	2012		2011
Revenues:
Rental income	$	23,663	$	17,561	$	6,102	35	%	$	5,663	$	439
Interest income	64		40		24		60	%	58		(34		)
Expenses:
Depreciation and amortization	7,303		6,086		1,217		20	%	1,467		(250		)
Interest	7,698		7,597		101		1	%	—		101
General and administrative	4,321		2,670		1,651		62	%	457		1,194

⁽¹⁾ Represents the dollar amount increase for the three months ended March 31, 2012 compared to the three months ended March 31, 2011 as a result of properties and other real estate-related assets acquired on or after January 1, 2011.

⁽²⁾ Represents dollar amount increase (decrease) for the three months ended March 31, 2012 compared to the three months ended March 31, 2011 with respect to properties and other real estate-related investments owned by us during both periods.

Rental Income

During the three months ended March 31, 2012, we recognized $23.7 million of rental income compared to $17.6 million, for the three months ended March 31, 2011. The $6.1 million net increase in rental income is primarily due to an increase of $5.7 million from properties acquired in 2011 and an increase of $0.4 million due to annual rent escalators related to properties owned prior to 2011. Amounts due under the terms of all of our lease agreements are subject to contractual increases, and there is no contingent rental income that may be derived from our properties.

Interest Income

During the three months ended March 31, 2012, we recognized $0.1 million of interest income, which consisted primarily of interest income earned on the Mezzanine Loan, which we originated on March 15, 2012.

Depreciation and Amortization

During the three months ended March 31, 2012, we incurred $7.3 million of depreciation and amortization expense compared to $6.1 million for the three months ended March 31, 2011. The $1.2 million net increase in depreciation and amortization was primarily due to an increase of $1.5 million from properties acquired in 2011, partially offset by a decrease of $0.3 million related to assets that have been fully depreciated. As of March 31, 2012, the purchase price allocations for our 2012 acquisitions are preliminary pending the receipt of information necessary to complete the valuation of certain tangible and intangible assets and liabilities and therefore are subject to change. Based on our current estimates, we expect depreciation and amortization expense to increase on an annual basis by $0.7 million as a result of our 2012 acquisitions.

Interest

We incur interest expense comprised of costs of borrowings plus the amortization of deferred financing costs related to our indebtedness. During the three months ended March 31, 2012, we incurred $7.7 million of interest expense compared to$7.6 million for the three months ended March 31, 2011. The increase of $0.1 million is due primarily to the increase in capacity under our Amended Secured Revolving Credit Facility from $100.0 million to $200.0 million and the resulting increase in unused facility fees. See “—Liquidity and Capital Resources” below for more information.

General and Administrative Expenses

General and administrative expenses include compensation-related expenses as well as professional services, office costs and other costs associated with acquisition pursuit activities. During the three months ended March 31, 2012, general and administrative expenses were $4.3 million compared to $2.7 million during the three months ended March 31, 2011. During the three months ended March 31, 2012, we incurred $0.5 million of acquisition pursuit costs. The majority of the remaining increase relates to an increase in stock-based compensation from $1.1 million during the three months ended March 31, 2011 to $2.2 million during the three months ended March 31, 2012. We expect acquisition pursuit costs to fluctuate from period to period depending on acquisition activity. We also expect stock-based compensation expense to fluctuate from period to period depending upon changes in our stock price and estimates associated with performance-based compensation.

26

Funds from Operations and Adjusted Funds from Operations

We believe that net income as defined by GAAP is the most appropriate earnings measure. We also believe that funds from operations (“FFO”), as defined in accordance with the definition used by the National Association of Real Estate Investment Trusts (“NAREIT”), and adjusted funds from operations ("AFFO") (and related per share amounts) are important non-GAAP supplemental measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets requires straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. However, since real estate values have historically risen or fallen with market and other conditions, presentations of operating results for a REIT that uses historical cost accounting for depreciation could be less informative. Thus, NAREIT created FFO as a supplemental measure of operating performance for REITs that excludes historical cost depreciation and amortization, among other items, from net income, as defined by GAAP. FFO is defined as net income, computed in accordance with GAAP, excluding gains or losses from real estate dispositions, plus real estate depreciation and amortization. AFFO is defined as FFO excluding non-cash revenues (including straight-line rental income adjustments and amortization of acquired above/below market lease intangibles), non-cash expenses (including stock-based compensation expense and amortization of deferred financing costs) and acquisition pursuit costs. We believe that the use of FFO and AFFO (and the related per share amounts), combined with the required GAAP presentations, improves the understanding of operating results of REITs among investors and makes comparisons of operating results among such companies more meaningful. We consider FFO and AFFO to be useful measures for reviewing comparative operating and financial performance because, by excluding gains or losses related to sales of previously depreciated operating real estate assets and real estate depreciation and amortization, and, for AFFO, by excluding non-cash revenues (including straight-line rental income adjustments and amortization of acquired above/below market lease intangibles), non-cash expenses (including stock-based compensation expense and amortization of deferred financing costs) and acquisition pursuit costs, FFO and AFFO can help investors compare our operating performance between periods or as compared to other companies. While FFO and AFFO are relevant and widely used measures of operating performance of REITs, they do not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating our liquidity or operating performance. FFO and AFFO also do not consider the costs associated with capital expenditures related to our real estate assets nor do they purport to be indicative of cash available to fund our future cash requirements. Further, our computation of FFO and AFFO may not be comparable to FFO and AFFO reported by other REITs that do not define FFO in accordance with the current NAREIT definition or that interpret the current NAREIT definition or define AFFO differently than we do.

The following table reconciles our calculations of FFO and AFFO for the three months ended March 31, 2012 and 2011, to net income, the most directly comparable GAAP financial measure, for the same periods (in thousands, except share and per share amounts):

	Three Months Ended March 31,
	2012			2011
Net income	$	4,405		$	1,248
Depreciation and amortization of real estate assets	7,303			6,086
FFO	11,708			7,334
Acquisition pursuit costs	491			87
Stock-based compensation	2,203			1,142
Straight-line rental income adjustments	(969		)	—
Amortization of deferred financing costs	566			495
AFFO	$	13,999		$	9,058
FFO per diluted common share	$	0.32		$	0.29
AFFO per diluted common share	$	0.38		$	0.35
Weighted average number of common shares outstanding, diluted:
FFO	37,058,886			25,211,585
AFFO	37,284,423			25,694,787

Included in net income above is general and administrative expense of $0.3 million related to one-time start-up costs incurred during the three months ended March 31, 2011. Please see the accompanying consolidated statement of cash flows for

27

details of our operating, investing, and financing cash activities.

Liquidity and Capital Resources

We believe that our available cash, operating cash flows and borrowings available to us under our Amended Secured Revolving Credit Facility provide sufficient funds for our operations, scheduled debt service payments with respect to the Senior Notes (as defined below) and mortgage indebtedness on our properties, and dividend requirements for the next twelve months. We have also filed with the SEC a shelf registration statement on Form S-3, which became effective on October 31, 2011, that will allow us to issue up to $500.0 million in new securities.

We intend to invest in additional healthcare properties as suitable opportunities arise and adequate sources of financing are available. We expect that future investments in properties, including any improvements or renovations of current or newly-acquired properties, will depend on and will be financed, in whole or in part, by our existing cash, borrowings available to us under our Amended Secured Revolving Credit Facility, future borrowings or the proceeds from additional issuances of common stock or other securities. In addition, we expect to seek financing from U.S. government agencies, including through Fannie Mae and HUD, in appropriate circumstances in connection with acquisitions and refinancings of existing mortgage loans.

In connection with the Separation and REIT Conversion Merger, we completed two significant debt financing transactions, as described below under “—Loan Agreements.” As of March 31, 2012, we had $225.0 million of indebtedness with respect to our Senior Notes and aggregate mortgage indebtedness to third parties of approximately $157.1 million on certain of our properties. In addition, as of March 31, 2012, we had $200.0 million available for borrowing under our Amended Secured Revolving Credit Facility.

Although we are subject to restrictions on our ability to incur indebtedness under the indenture governing the Senior Notes and under the terms of our Amended Secured Revolving Credit Facility, we expect that we will be able to refinance existing indebtedness or incur additional indebtedness for acquisitions or other purposes, if needed. However, there can be no assurance that in the future we will be able to refinance our indebtedness, incur additional indebtedness or access additional sources of capital, such as by issuing common stock or other debt or equity securities, on terms that are acceptable to us or at all.

Cash Flows from Operating Activities

Net cash provided by operating activities was $16.5 million and $12.5 million for the three months ended March 31, 2012 and 2011, respectively. This was derived primarily from the rental payments received under the lease agreements with subsidiaries of Sun and rental payments from our other tenants following the date of our acquisition of the underlying property we are leasing to them. We expect our annualized cash flows provided by operating activities to increase as a result of completed and anticipated future real estate investment acquisitions.

Cash Flows from Investing Activities

During the three months ended March 31, 2012, net cash used in investing activities was $40.2 million and consisted of $29.9 million used in the acquisition of the Pennsylvania Subacute Portfolio and $10.1 million used for the Mezzanine Loan. During the three months ended March 31, 2011, net cash used in investing activities was $5.4 million and consisted of $5.3 million used for the acquisition of a note receivable and $86,000 used for purchases of furniture and equipment for our corporate office. We expect our cash flows used in investing activities to increase as a result of anticipated future real estate investment acquisitions.

Cash Flows from Financing Activities

During the three months ended March 31, 2012, net cash used in financing activities was $15.8 million and consisted of $0.4 million from payments related to the issuance of common stock, $12.2 million of dividends paid to common stockholders, $0.8 million of principal repayments of mortgage notes payable and $2.5 million of payments for deferred financing costs primarily related to the entry into the Amended Secured Revolving Credit Facility. During the three months ended March 31, 2011, net cash used in financing activities was $1.1 million and consisted of $0.8 million of principal repayments of mortgage notes payable and $0.3 million of payments for deferred financing costs.

Loan Agreements

8.125% Senior Notes due 2018. On October 27, 2010, we, through the Operating Partnership and Sabra Capital Corporation (the “Issuers”), issued $225.0 million aggregate principal amount of senior unsecured notes (the “Senior Notes”) in a private placement. The Senior Notes were sold at par, resulting in gross proceeds of $225.0 million and net proceeds of approximately $219.9 million after deducting commissions and expenses. On December 6, 2010, substantially all of the net

28

proceeds were used by Sun to redeem the $200.0 million in aggregate principal amount outstanding of Old Sun’s 9.125% senior subordinated notes due 2015, including accrued and unpaid interest and the applicable redemption premium. In March 2011, the Issuers completed an exchange offer to exchange the Senior Notes for substantially identical 8.125% senior unsecured notes registered under the Securities Act of 1933, as amended (also referred to herein as the “Senior Notes”).

The obligations under the Senior Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by us and certain of our other existing and, subject to certain exceptions, future subsidiaries; provided, however, that such guarantees are subject to release under certain customary circumstances.  See Note 9, "Summarized Condensed Consolidating Information," in the Notes to Condensed Consolidated Financial Statements for additional information concerning the circumstances pursuant to which the guarantors will be automatically and unconditionally released from their obligations under the guarantees.

The Senior Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, on or after November 1, 2014, at the redemption prices set forth in the indenture governing the Senior Notes (the “Indenture”), plus accrued and unpaid interest to the applicable redemption date. In addition, prior to November 1, 2014, the Issuers may redeem all or a portion of the Senior Notes at a redemption price equal to 100% of the principal amount of the Senior Notes redeemed, plus a “make-whole” premium, plus accrued and unpaid interest to the applicable redemption date. At any time, or from time to time, on or prior to November 1, 2013, the Issuers may redeem up to 35% of the principal amount of the Senior Notes, using the proceeds of specific kinds of equity offerings, at a redemption price of 108.125% of the principal amount to be redeemed, plus accrued and unpaid interest, if any, to the applicable redemption date. Assuming the Senior Notes are not redeemed, the Senior Notes mature on November 1, 2018.

The Indenture governing the Senior Notes contains restrictive covenants that, among other things, restrict the ability of Sabra, the Issuers and their restricted subsidiaries to: (i) incur or guarantee additional indebtedness; (ii) incur or guarantee secured indebtedness; (iii) pay dividends or distributions on, or redeem or repurchase, their capital stock; (iv) make certain investments or other restricted payments; (v) sell assets; (vi) create liens on their assets; (vii) enter into transactions with affiliates; (viii) merge or consolidate or sell all or substantially all of their assets; and (ix) create restrictions on the ability of Sabra and its restricted subsidiaries to pay dividends or other amounts to Sabra. The Indenture governing the Senior Notes also provides for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the Senior Notes, the failure to comply with certain covenants and agreements specified in the Indenture for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then outstanding Senior Notes may become due and payable immediately. As of March 31, 2012, we were in compliance with all applicable financial covenants under the Senior Notes.

Secured Revolving Credit Facility. On November 3, 2010, the Borrowers entered into a secured revolving credit facility with certain lenders as set forth in the related credit agreement and Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer (each as defined in such credit agreement), as amended on February 10, 2012 to increase the borrowing capacity from $100.0 million to $200.0 million (up to $20.0 million of which may be utilized for letters of credit) and to include an accordion feature that allows the Borrowers to increase borrowing availability up to an additional $150.0 million, subject to certain terms and conditions. We refer to the secured revolving credit facility, as amended, as the “Amended Secured Revolving Credit Facility.” The Amended Secured Revolving Credit Facility is secured by, among other things, a first priority lien against certain of the properties owned by certain of our subsidiaries. The obligations of the Borrowers under the Amended Secured Revolving Credit Facility are guaranteed by us and certain of our subsidiaries. Borrowing availability under the Amended Secured Revolving Credit Facility is subject to a borrowing base calculation based on, among other factors, the lesser of (i) the mortgageability cash flow (as such term is defined in the credit agreement relating to the Amended Secured Revolving Credit Facility) or (ii) the appraised value, in each case of the properties securing the Amended Secured Revolving Credit Facility. Borrowing availability under the Amended Secured Revolving Credit Facility terminates, and all borrowings mature, on February 10, 2015, subject to a one-year extension option. The entire $200.0 million was available for borrowing under the Amended Secured Revolving Credit Facility as of March 31, 2012. Borrowing availability under the Amended Secured Revolving Credit Facility terminates, and all borrowings mature, on February 10, 2015, subject to a one-year extension option. As of March 31, 2012, there were no amounts outstanding under the Amended Secured Revolving Credit Facility.

Borrowings under the Amended Secured Revolving Credit Facility bear interest on the outstanding principal amount at a rate equal to an applicable percentage plus, at the Borrowers' option, either (a) LIBOR or (b) a base rate determined as the greater of (i) the federal funds rate plus 0.5%, (ii) the prime rate, and (iii) one-month LIBOR plus 1.0% (the “Base Rate”). The applicable percentage for borrowings will vary based on the Consolidated Leverage Ratio, as defined in the credit agreement, and will range from 2.00% to 3.00% per annum for borrowings at the Base Rate and 3.00% to 4.00% per annum for LIBOR based borrowings. In addition, the Borrowers are required to pay a facility fee to the lenders equal to between 0.35% and 0.50% per annum based on the amount of unused borrowings under the Amended Secured Revolving Credit Facility.

29

The Amended Secured Revolving Credit Facility contains customary covenants that include restrictions on the ability to make acquisitions and other investments, pay dividends, incur additional indebtedness, engage in non-healthcare related business activities, enter into transactions with affiliates and sell or otherwise transfer certain assets as well as customary events of default. The Amended Secured Revolving Credit Facility also requires that we, through the Borrowers, comply with specified financial covenants, which include a maximum leverage ratio, a minimum fixed charge coverage ratio and a minimum tangible net worth requirement. As of March 31, 2012, we were in compliance with all applicable financial covenants under the Amended Secured Revolving Credit Facility.

Mortgage Indebtedness

Of our 99 properties, 26 are subject to mortgage indebtedness to third parties that, as of March 31, 2012, totaled approximately $157.1 million. As of March 31, 2012 and December 31, 2011, our mortgage notes payable consisted of the following (dollars in thousands):

Interest Rate Type	Principal Outstanding as of March 31, 2012 (2)		Principal Outstanding as of December 31, 2011 (2)		Weighted Average Interest Rate at March 31, 2012		Maturity Date
Fixed Rate	$	98,249	$	98,739	6.29	%	August 2015 - June 2047
Variable Rate(1)	58,858		59,159		5.50	%	August 2015
	$	157,107	$	157,898

⁽¹⁾  Contractual interest rates under variable rate mortgages are equal to the 90-day LIBOR plus 4.5% (subject to a 1.0% LIBOR floor).

⁽²⁾  Outstanding principal balance for mortgage indebtedness does not include mortgage premium of $0.5 million as of March 31, 2012 and December 31, 2011.

Capital Expenditures

For the three months ended March 31, 2011, our aggregate capital expenditures were $9,000, which was primarily for corporate office needs. There were no capital expenditures for the three months ended March 31, 2012. There are no present plans for the improvement or development of any unimproved or undeveloped property; however, from time to time we may agree to fund improvements our tenants make at our facilities. Accordingly, we anticipate that our aggregate capital expenditure requirements for fiscal year 2012 will not exceed $10.0 million, and that such expenditures will principally be for improvements to our facilities and result in incremental rental income.

Dividends

We paid dividends of $12.2 million during the three months ended March 31, 2012. On April 24, 2012, our board of directors declared a quarterly cash dividend of $0.33 per share of common stock. The dividend will be paid on May 31, 2012 to stockholders of record as of May 15, 2012.

Change in Skilled Nursing Facility Reimbursement Rates

Medicare reimburses skilled nursing facilities for Medicare Part A services under the Prospective Payment System (“PPS”), as implemented pursuant to the Balanced Budget Act of 1997 and modified pursuant to subsequent laws, most recently the Patient Protection and Affordable Care Act of 2010 (the “Affordable Care Act”). PPS regulations predetermine a payment amount per patient, per day, based on a market basket index calculated for all covered costs. The amount to be paid is determined by classifying each patient into one of 66 Resource Utilization Group (“RUG”) categories that represent the level of services required to treat different conditions and levels of acuity.

The current system of 66 RUG categories, or Resource Utilization Group version IV (“RUG IV”), became effective as of October 1, 2010. RUG IV resulted from research performed by CMS and was part of CMS's continuing effort to increase the correlation of the cost of services to the condition of individual patients.

On July 29, 2011, CMS released its final rule regarding 2012 Medicare payment rates for skilled nursing facilities, which became effective October 1, 2011. Based on the final rule, the net reduction in fiscal year 2012 Medicare reimbursement rates for skilled nursing facilities will be 11.1%. On January 4, 2012, Sun issued a press release announcing its 2012 financial outlook and guidance, in which Sun stated that it expected the net impact of the final rule in 2012 to be between $40 million to $45 million after mitigation strategies were implemented to partially offset the impact of the CMS final rule. Based on Sun's expected 2012 consolidated EBITDAR (earnings before interest, taxes, depreciation, amortization and rent) of between $222.0 million and $228.0 million and expected consolidated rents across all of its facilities totaling $148.0 million, Sun's expected

30

2012 consolidated EBITDAR coverage would be between 1.50x and 1.54x (Sun's expected 2012 consolidated EBITDAR coverage would be between 1.46x and 1.50x before eliminating assets Sun expects to transition to held for sale status in 2012). Sun's actual consolidated EBITDAR and consolidated rents across all of its facilities for the three months ended March 31, 2012, was $52.3 million and $36.4 million, respectively. Sun's consolidated EBITDAR coverage for the three months ended March 31, 2012 was 1.44x. Subsequent to March 31, 2012, CMS released projections for fiscal year 2013 Medicare rate reimbursement for skilled nursing facilities of a net increase of 2.2% over fiscal year 2012 payments (comprised of a market basket increase of 3.0% less the productivity adjustment of 0.8%).

In addition to Sun, other tenants have undertaken cost and patient mix mitigation activities intended to partially offset the impact of the CMS final rule. Although there has been no negative impact on our tenants' ability to pay their lease obligations to date, if Sun and our other skilled nursing facility tenants are unable to mitigate the impact of the CMS final rule as expected, this may have an adverse impact on their business and financial results, which will adversely affect our business, financial position or results of operations if they are unable to timely make their rental payments to us.

Obligations and Commitments

The following table summarizes our contractual obligations and commitments in future years, including our Senior Notes and our mortgage indebtedness to third parties on certain of our properties that, as of March 31, 2012, totaled $157.1 million. The following table is presented as of March 31, 2012 (in thousands):

			April 1, 2012 through				Year Ended December 31,
	Total		December 31, 2012		2013		2014		2015		2016		After 2016
Mortgage indebtedness(1)	$	239,458	$	9,512	$	12,680	$	12,678	$	93,170	$	5,333	$	106,085
Senior Notes(2)	352,968		18,281		18,281		18,281		18,281		18,281		261,563
Operating lease	342		65		91		95		91		—		—
Total	$	592,768	$	27,858	$	31,052	$	31,054	$	111,542	$	23,614	$	367,648

⁽¹⁾  Mortgage indebtedness includes principal payments and interest payments through the maturity dates. Total interest on mortgage indebtedness, based on contractual rates, is $82.4 million, of which $10.8 million is attributable to variable interest rates determined using the weighted average method.

⁽²⁾  Senior Notes includes interest payments payable semi-annually each May 1st and November 1st at a fixed rate of 8.125%. The Senior Notes mature on November 1, 2018. Total interest on the Senior Notes is $128.0 million.

Off-Balance Sheet Arrangements

None.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our primary market risk exposure is interest rate risk with respect to our indebtedness. As of March 31, 2012, this indebtedness included the $225.0 million aggregate principal amount of Senior Notes outstanding and $157.1 million of mortgage indebtedness to third parties on certain of the properties that our subsidiaries own. As of March 31, 2012, we had $58.9 million of outstanding variable rate mortgage indebtedness. In addition, as of March 31, 2012, we had $200 million available for borrowing under our Amended Secured Revolving Credit Facility (which amount increased from $100 million following the amendment of the secured revolving credit facility on February 10, 2012), although no borrowings were outstanding as of March 31, 2012. From time to time, however, we may borrow under the Amended Secured Revolving Credit Facility to finance future investments in properties, including any improvements or renovations of current or newly acquired properties, or for other purposes. Because borrowings under the Amended Secured Revolving Credit Facility bear interest on the outstanding principal amount at a rate equal to an applicable percentage plus, at our option, either (a) LIBOR or (b) a base rate determined as the greater of (i) the federal funds rate plus 0.5%, (ii) the prime rate, and (iii) one-month LIBOR plus 1.0%, the interest rate we will be required to pay on any such borrowings will depend on then applicable rates and may vary. An increase in interest rates could make the financing of any acquisition by us more costly. Rising interest rates could also limit our ability to refinance our debt when it matures or cause us to pay higher interest rates upon refinancing and increase interest expense on refinanced indebtedness. Assuming a 100 basis point increase in the interest rate related to our variable rate debt, and assuming no change in our outstanding debt balance as of March 31, 2012, interest expense would increase $0.1 million for the twelve months following March 31, 2012. As the index underlying our variable rate mortgages is currently below 100 basis points and is not expected to go below zero and after giving consideration to interest rate floors imbedded in our variable rate

31

debt agreements, interest expense would not be expected to be impacted by a decline in current interest rates.

We expect to manage our exposure to interest rate risk by maintaining a mix of fixed and variable rates for our indebtedness. We also may manage, or hedge, interest rate risks related to our borrowings by means of interest rate swap agreements, although we are not currently a party to any swap agreements.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

As of the end of the period covered by this report, management, including our chief executive officer and chief financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures. Based upon, and as of the date of, the evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2012 to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the "Exchange Act") is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our chief executive officer and our chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended March 31, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

32

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None of the Company or any of its subsidiaries is a party to, and none of their respective property is the subject of, any material legal proceeding, although we are from time to time party to legal proceedings that arise in the ordinary course of our business.

ITEM 1A. RISK FACTORS

There have been no material changes in our assessment of our risk factors from those set forth in our 2011 Annual Report on Form 10-K.

ITEM 6. EXHIBITS

Ex.	Description
2.1	Agreement and Plan of Merger, dated as of September 23, 2010, by and between Sun Healthcare Group, Inc. and Sabra Health Care REIT, Inc. (incorporated by reference to Annex A to the proxy statement/prospectus included in Amendment No. 4 to the Registration Statement on Form S-4 (File No. 333-167040) filed by Sabra Health Care REIT, Inc. on September 28, 2010).
2.2	Distribution Agreement, dated November 4, 2010, by and among Sun Healthcare Group, Inc., Sabra Health Care REIT, Inc. and SHG Services, Inc. (which has been renamed Sun Healthcare Group, Inc.) (incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on November 5, 2010).†
2.3	Purchase and Sale Agreement and Joint Escrow Instructions, dated July 8, 2011, by and between Peninsula Healthcare Services, LLC; Broadmeadow Investment LLC; Capitol Nursing & Rehabilitation Center, L.L.C.; and Pike Creek Healthcare Services LLC, and Sabra Health Care REIT, Inc. (incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on July 11, 2011).
3.1	Articles of Amendment and Restatement of Sabra Health Care REIT, Inc., dated October 20, 2010, filed with the State Department of Assessments and Taxation of the State of Maryland on October 21, 2010 (incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on October 26, 2010).
3.2	Amended and Restated Bylaws of Sabra Health Care REIT, Inc. (incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed by Sabra Health Care REIT, Inc. on October 26, 2010).
10.1*+	Sabra Health Care REIT, Inc. 2012 Bonus Plan.
10.2*+	Sabra Health Care REIT, Inc. Directors' Compensation Policy.
12.1*	Statement Re: Computation of Ratios of Earnings to Fixed Charges.
31.1*	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002.

33

32.2*	Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*	XBRL Instance Document.
101.SCH*	XBRL Taxonomy Extension Schema Document.
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document.

* Filed herewith.

+ Designates a management compensation plan, contract or arrangement.

† Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Registrants hereby agree to furnish supplementally copies of any of the omitted schedules and exhibits upon request by the Securities and Exchange Commission.

34

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SABRA HEALTH CARE REIT, INC.
Date: May 8, 2012	By:	/S/    RICHARD K. MATROS
		Richard K. Matros
		Chairman, President and
		Chief Executive Officer
		(Principal Executive Officer)
Date: May 8, 2012	By:	/S/    HAROLD W. ANDREWS, JR.
		Harold W. Andrews, Jr.
		Executive Vice President,
		Chief Financial Officer and Secretary
		(Principal Financial and Accounting Officer)

35

EX-10.1

SABRA HEALTH CARE REIT, INC.

2012 BONUS PLAN

This Sabra Health Care REIT, Inc. 2012 Bonus Plan (this “Bonus Plan”) sets forth the terms of the fiscal 2012 annual incentive bonus opportunity for employees selected to participate in this Bonus Plan (each, a “Participant”). For Participants who are expected to be impacted by the deductibility limits of Section 162(m) (“Section 162(m)”) of the United States Internal Revenue Code of 1986, as amended (the “Code”), this Bonus Plan is intended to provide bonuses that qualify as performance-based compensation within the meaning of Section 162(m). With respect to Participants who are expected to be impacted by the deductibility limits of Section 162(m), this Bonus Plan is adopted under Section 5.2 of the Sabra Health Care REIT, Inc. 2009 Performance Incentive Plan (the “Plan”), and bonuses payable under this Bonus Plan to such Participants shall be subject to all of the terms and conditions of the Plan applicable to Performance-Based Awards. Capitalized terms are defined in the Plan if not defined herein.

1. ADMINISTRATION

This Bonus Plan shall be administered by the Compensation Committee of the Board (the “Committee”), which shall consist solely of two or more members of the Board who are “outside directors” within the meaning of Section 162(m). The Committee shall act as the Administrator of this Bonus Plan, and shall have all of the administrative authority and powers with respect to this Bonus Plan as specified in the Plan.

2. AWARDS

Each Participant will be granted an “Award” under this Bonus Plan. Each Award granted to a Participant represents the opportunity to receive a payment for the Corporation’s 2012 fiscal year (the “Performance Period”) determined under the terms and conditions of this Bonus Plan (a “Bonus”). The Committee shall establish the target amount of each Participant’s Bonus during the first ninety (90) days of the Performance Period, although the target Bonus amount for Participants selected to participate in this Bonus Plan after this period may be established at a later date. For Participants other than the Section 162(m) Officers (as defined below), the Committee may delegate to the Corporation’s President and Chief Executive Officer the authority to establish the target amount of each such Participant’s Bonus.

3. SECTION 162(M) PERFORMANCE REQUIREMENTS

3.1 EPS Performance Goal. Notwithstanding any other provisions of this Bonus Plan, no Bonus shall be paid to any of Richard K. Matros, Harold W. Andrews, Jr. or Talya Nevo-Hacohen (each, a “Section 162(m) Officer”) unless the Corporation achieves an EPS target of $0.50 for the Performance Period (the “EPS Target”). If the Corporation fails to achieve the EPS Target, no Bonuses shall be paid to any Section 162(m) Officers, and all of their rights under this Bonus Plan will automatically terminate. For purposes of this Bonus Plan, “EPS” means the Corporation’s basic earnings per common or common equivalent share as determined on a consolidated basis in accordance with generally accepted accounting principles as applied in the Corporation’s financial reporting. When determining EPS, the Committee shall make adjustments to the EPS Target to eliminate the effect of (i) discontinued operations, (ii) the purchase or disposition of a business, or (iii) any change in accounting policies or practices.

3.2 Maximum Bonus Amounts. If the Corporation achieves the EPS Target, the maximum Bonus payable to any Section 162(m) Officer shall be as follows:

• For the Corporation’s President and Chief Executive Officer, the maximum Bonus shall equal the greater of (1) $1,400,000 and (2) the aggregate value of (x) 115,800 shares of Common Stock on the date the Bonus is paid (which number of shares had a value of approximately $1,400,000 based on the closing price of our Common Stock on December 30, 2011), plus (y) the aggregate amount of any ordinary cash dividends paid on such number of shares for which the record date is between January 1, 2012 and the date the Bonus is paid; and

• For all other Section 162(m) Officers, the maximum Bonus shall equal the greater of (1) $700,000 and (2) the aggregate value of (x) 57,900 shares of Common Stock on the date the Bonus is paid (which number of shares had a value of approximately $700,000 based on the closing price of our Common Stock on December 30, 2011), plus (y) the aggregate amount of any ordinary cash dividends paid on such number of shares for which the record date is between January 1, 2012 and the date the Bonus is paid.

In no case, however, shall the amount of any Section 162(m) Officer’s Bonus exceed the applicable limit set forth in Section 5.2.3 of the Plan.

3.3 Negative Discretion. For the avoidance of doubt, the Committee may exercise negative discretion by reducing the amount of the Bonus payable to any Section 162(m) Officer from the maximum potential Bonus amounts specified in Section 3.2. The determination of Bonus amounts for Section 162(m) Officers pursuant to the other provisions of this Bonus Plan shall be considered such an exercise of negative discretion. For purposes of clarity, no such reduction shall increase the amount of the maximum Bonus payable to any other Section 162(m) Officer.

4. COMPLETED ACQUISITIONS PERFORMANCE CRITERIA

Subject to the limits of Section 3 and the provisions of this Section 4, the amount of each Participant’s Bonus shall be based upon the U.S. dollar value of real property acquisitions for the Corporation’s portfolio completed during the Performance Period (“Acquisitions”) as a percentage of the targeted dollar value of Acquisitions established for the Performance Period as follows:

Percentage of Targeted Dollar Value of Acquisitions Attained (%)	Percentage of Target Bonus Becoming Payable as a Bonus (%)
Threshold Level	50%
First Intermediate Level	75%
100% (Target Level)	100%
Second Intermediate Level	125%
Third Intermediate Level	150%
Maximum Level	175%

If the dollar value of Acquisitions attained is between the threshold level and the first intermediate level, between the first intermediate level and the target level, between the target level and the second intermediate level, between the second and third intermediate levels or between the third intermediate level and the maximum level, the percentage of each Participant’s target bonus amount becoming payable as a Bonus shall be pro-rated on a straight-line basis between the closest two percentages listed in the table above. The Committee shall establish the threshold, all intermediate, the target and the maximum levels of Acquisitions for the Performance Period during the first ninety (90) days of the Performance Period.

Notwithstanding the other provisions of this Section 4, the Committee has discretion to reduce (but not increase) the Bonus otherwise payable to any one or more Participants based on the dollar value of Acquisitions attained. The Committee may exercise such discretion on any basis it deems appropriate.

5. NEWLY-HIRED PARTICIPANTS

If any Participant is selected to participate in this Bonus Plan after the first quarter of the Performance Period has elapsed, the Committee shall have the discretion to make appropriate pro-rata adjustments to the target amount of the Participant’s Bonus, the dollar value of Acquisitions targets contained in Section 4 and to any of the other terms and conditions of this Bonus Plan.

6. COMMITTEE DETERMINATION AND CERTIFICATION.

As soon as practicable after the end of the Performance Period, the Committee shall determine the amount of the Corporation’s EPS attained for the Performance Period and the dollar value of Acquisitions attained for the Performance Period. At this time, the Committee shall also determine the amount of each Participant’s Bonus payable pursuant to this Bonus Plan. No Bonus shall be paid to a Section 162(m) Officer unless and until the Committee has certified, by resolution or other appropriate action in writing, (1) that the EPS Target has been achieved, (2) the dollar value of Acquisitions attained for the Performance Period as a percentage of the targeted dollar value of Acquisitions established for the Performance Period, (3) the amount of the Bonus earned by each Section 162(m) Officer and (4) that any other material terms previously established by the Committee or set forth in this Bonus Plan applicable to the Bonus were in fact satisfied.

7. CONTINUED EMPLOYMENT REQUIREMENT

Unless otherwise provided in a Participant’s employment agreement with the Corporation, a Participant must remain continuously employed by the Corporation or one of its Subsidiaries through the last day of the Performance Period in order for any Bonus to become payable pursuant to this Bonus Plan. Unless otherwise provided in a Participant’s employment agreement with the Corporation, if a Participant terminates employment with the Corporation or one of its Subsidiaries for any reason prior to the last day of the Performance Period, all of the Participant’s rights under this Bonus Plan will automatically terminate.

8. PAYMENT OF BONUSES    

Any Bonuses becoming payable pursuant to this Bonus Plan shall be paid to each Participant as soon as practicable following the end of the Performance Period and, for Section 162(m) Officers, after the Committee’s certification described in Section 6 above, with all Bonuses to be paid no later than March 11, 2013. For any Participant who failed to make any election with respect to this Bonus Plan or who previously elected to receive payment of any Bonus becoming payable pursuant to this Bonus Plan in cash, his or her Bonus shall be paid in cash. For any Participant who previously elected to receive payment of any Bonus becoming payable pursuant to this Bonus Plan in shares of Common Stock, his or her Bonus shall be paid in a number of shares of Common Stock equal to (x) the amount of the Bonus divided by (y) the closing price of a share of Common Stock on December 30, 2011 (such number of shares, the “Earned Shares”). As part of the Participant’s Bonus, any Participant receiving payment in shares of Common Stock shall also be paid an additional number of shares of Common Stock equal to (1) the aggregate amount of any ordinary cash dividends paid on the Earned Shares for which the record date is between January 1, 2012 and the date the Earned Shares are paid divided by (2) the closing price of a share of Common Stock on the date immediately preceding the date the Earned Shares are paid.

9. ADJUSTMENTS    

Any Awards granted under this Bonus Plan, together with any shares of Common Stock payable pursuant to this Bonus Plan, shall be subject to the adjustment and corporate transaction provisions of Section 7 of the Plan.

10. RECOUPMENT OF BONUS PAYMENTS

Any Bonuses becoming payable pursuant to this Bonus Plan shall be subject to the terms of the Corporation’s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the Bonuses or any shares of Common Stock or other cash or property received with respect to the Bonuses (including any value received from a disposition of the shares acquired upon payment of the Bonuses).

11. GENERAL PROVISIONS

11.1 Rights of Participants.

(a) No Right to Continued Employment. Nothing in this Bonus Plan (or in any other documents evidencing any Award under this Bonus Plan) will be deemed to confer on any Participant any right to continue in the employ of the Corporation or any Subsidiary or interfere in any way with the right of the Corporation or any Subsidiary to terminate his or her employment at any time.

(b) Bonus Plan Not Funded. No Participant or other person will have any right or claim to any specific funds, property or assets of the Corporation by reason of any Award hereunder. To the extent that a Participant or other person acquires a right to receive payment pursuant to any Award hereunder, such right shall be no greater than the right of any unsecured general creditor of the Corporation.

11.2 Force and Effect. The various provisions herein are severable in their entirety. Any determination of invalidity or unenforceability of any one provision will have no effect on the continuing force and effect of the remaining provisions.

11.3 Governing Law. This Bonus Plan will be construed under the laws of the State of Maryland.

11.4 Construction.

(a) Section 162(m). It is the intent of the Corporation that, with respect to any Section 162(m) Officers, this Bonus Plan, Awards and Bonuses paid hereunder will qualify as performance-based compensation or will otherwise be exempt from deductibility limitations under Section 162(m). Any provision, application or interpretation of this Bonus Plan inconsistent with this intent to satisfy the standards in Section 162(m) shall be disregarded.

(b) Section 409A. It is intended that Awards granted and Bonuses paid under this Bonus Plan qualify as “short-term deferrals” within the meaning of the guidance provided by the Internal Revenue Service under Section 409A of the Code and this Bonus Plan shall be interpreted consistent with that intent.

11.5 Tax Withholding. Any Bonuses becoming payable pursuant to this Bonus Plan shall be subject to the Corporation’s tax withholding rights in Section 8.5 of the Plan. With respect to any Participant who receives payment of any Bonus becoming payable pursuant to this Bonus Plan in shares of Common Stock, the Participant’s previous tax withholding election (if any) under the Plan shall apply to any shares of Common Stock that are paid, and shall determine whether the Corporation satisfies its withholding obligations by requiring the Participant to pay or provide for cash payment or by reducing the number of shares otherwise deliverable.

EX-10.2

SABRA HEALTH CARE REIT, INC.

DIRECTORS’ COMPENSATION POLICY

(Effective June 21, 2012)

Directors of Sabra Health Care REIT, Inc., a Maryland corporation (the “Company”), who are not employed by the Company or one of its subsidiaries (“non-employee directors”) are entitled to the compensation set forth below for their service as a member of the Board of Directors (the “Board”) of the Company. The Board has the right to amend this policy from time to time.

Cash Compensation
Annual Retainer	$50,000
Additional Chair/Lead Independent Director Retainer	$20,000
Additional Committee Chair Retainers
Audit Committee Chair	$12,500
Compensation Committee Chair	$7,500
Nominating and Governance Committee Chair	$7,500
Committee Meeting Fee (per meeting)	$1,000
Equity Compensation
Annual Equity Award	$40,000
Initial Equity Award	$20,000

Cash Compensation

Each non-employee director will be entitled to an annual cash retainer while serving on the Board in the amount set forth above (the “Annual Retainer”). A non-employee director who serves as the Chair of the Board or the Company’s Lead Independent Director will be entitled to an additional annual cash retainer while serving in that position in the amount set forth above (the “Additional Chair/Lead Independent Director Retainer”). A non-employee director who serves as the Chair of the Audit Committee, the Compensation Committee or the Nominating and Governance Committee of the Board will be entitled to an additional annual cash retainer while serving in that position in the applicable amount set forth above (an “Additional Committee Chair Retainer”). A non-employee director who attends a meeting of the Audit Committee, the Compensation Committee or the Nominating and Governance Committee of the Board (each, a “Committee Meeting”) will be entitled to a fee for attendance at the meeting in the amount set forth above (a “Committee Meeting Fee”); provided that the Committee Meeting Fee for a particular Committee Meeting will be reduced to $500 if the meeting is either (1) a telephonic meeting lasting for less than thirty minutes, or (2) a meeting that is held as an in-person meeting but the non-employee director attends the meeting other than in person.

The amounts of the Annual Retainer, Additional Chair/Lead Independent Director Retainer, and Additional Committee Chair Retainers reflected above are expressed as annualized amounts. These retainers will be paid on a quarterly basis, at the end of each quarter in arrears, and will be pro-rated if a non-employee director serves (or serves in the corresponding position, as the case may be) for only a portion of the quarter (with the proration based on the number of calendar days in the quarter that the director served as a non-employee director or held the particular position, as the case may be). Committee Meeting Fees for attendance at one or more meetings that occur in a particular quarter will be paid at the end of that quarter.

Equity Awards

Initial Equity Awards

For each new non-employee director appointed or elected to the Board, on the date that the new non-employee director first becomes a member of the Board, the new non-employee director will automatically be granted an award of restricted stock units (an “Initial RSU Award”) determined by dividing (1) the Initial Equity Award grant value set forth above by (2) the per-share closing price of the Company’s common stock on the date of grant (rounded down to the nearest whole unit). Each Initial RSU Award will vest in equal monthly installments over the two-year period following the date of grant.

An employee or former employee of the Company or one of its subsidiaries who ceases or has ceased to be so employed and becomes a non-employee director will not be eligible for an Initial RSU Award grant, but will be eligible for cash compensation and annual equity awards on the same basis as other non-employee directors.

Annual Equity Awards for Continuing Board Members

On the date of each annual meeting of the Company’s stockholders, each non-employee director then in office will automatically be granted an award of restricted stock units (an “Annual RSU Award”) determined by dividing (1) the Annual Equity Award grant value set forth above by (2) the per-share closing price of the Company’s common stock on the date of such annual meeting (rounded down to the nearest whole unit). Each Annual RSU Award will vest in equal monthly installments over the one-year period following the date of grant. Should the annual meeting of the Company’s stockholders in the year following the year in which the award was granted occur prior to the last vesting date of the award, the outstanding and unvested portion of the award will vest on the day prior to that annual meeting. In the event that more than one annual meeting of the Company’s stockholders occurs during a given fiscal year, Annual RSU Awards will be made only in connection with the first such meeting to occur in that year.

For each new non-employee director appointed or elected to the Board other than on the date of an annual meeting of the Company’s stockholders, on the date that the new non-employee director first becomes a member of the Board, the new non-employee director will be entitled to a pro-rata portion of the Annual RSU Award (a “Pro-Rata Annual RSU Award”) determined by dividing (1) a pro-rata portion of the Annual Equity Award grant value set forth above by (2) the per-share closing price of the Company’s common stock on the date the new non-employee director first became a member of the Board. The pro-rata portion of the Annual Equity Award grant value for purposes of a Pro-Rata Annual RSU Award will equal the Annual Equity Award grant value set forth above multiplied by a fraction (not greater than one), the numerator of which is 12 minus the number of whole months that as of the particular grant date had elapsed since the Company’s last annual meeting of stockholders at which Annual RSU Awards were granted by the Company to non-employee directors, and the denominator of which is 12, with the result to be rounded down to the nearest whole unit. Each Pro-Rata Annual RSU Award will vest in equal monthly installments based on the number of whole months remaining in the period beginning with the month following the month in which the Pro-Rata Annual RSU Award was granted and ending with the month in which the next scheduled annual meeting of the Company’s stockholders in which Annual RSU Awards will be granted.

Provisions Applicable to All Non-Employee Director Equity Awards

Each restricted stock unit award will be made under and subject to the terms and conditions of the Company’s 2009 Performance Incentive Plan (the “2009 Plan”) or any successor equity compensation plan approved by the Company’s stockholders and in effect at the time of grant, and will be evidenced by, and subject to the terms and conditions of, an award agreement in the form approved by the Board to evidence such type of grant pursuant to this policy (the “Form of Award Agreement”). To the extent then vested, restricted stock units will generally be paid in an equal number of shares of the Company’s common stock on the earlier to occur of (1) that date that is five years following the original grant date, (2) the date the non-employee director ceases to be a member of the Board, or (3) the occurrence of a “change in control.”

Restricted stock unit awards granted under the 2009 Plan are generally forfeited as to the unvested portion of the award upon the non-employee director’s termination of service as a director for any reason. However, vesting of a non-employee director’s outstanding and unvested restricted stock units will accelerate upon a change in control of the Company or should the director’s services terminate due to the director’s death or disability.

Non-employee directors are entitled to receive dividend equivalents with respect to outstanding and unpaid restricted stock units granted pursuant to this policy. Dividend equivalents, if any, are paid in the form of a credit of additional restricted stock units under the 2009 Plan and are subject to the same vesting, payment and other provisions as the underlying restricted stock units.

The definition of “change in control” and specific payment, termination and dividend equivalent provisions applicable to an award are set forth in the related Form of Award Agreement.

Elective Grants of Equity Awards

Non-employee directors may participate in the Company’s Non-Employee Directors Stock-For-Fees Program, pursuant to which they may elect that certain of their cash retainers be converted into the right to receive an award of stock units under the 2009 Plan.

Expense Reimbursement

All non-employee directors will be entitled to reimbursement from the Company for their reasonable travel (including airfare and ground transportation), lodging and meal expenses incident to meetings of the Board or committees thereof or in connection with other Board related business. The Company will make reimbursement to a non-employee director within a reasonable amount of time following submission by the non-employee director of reasonable written substantiation for the expenses.

EX-12.1

SABRA HEALTH CARE REIT, INC. AND SUBSIDIARIES

COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES

(dollars in thousands)

		Three Months Ended March 31,
		2012		2011
Earnings
	Pre-tax net income	$	4,405	$	1,248
	Add:
	Fixed charges	7,705		7,602
	Earnings, as adjusted	$	12,110	$	8,850
Fixed charges
	Interest expensed and capitalized	$	7,136	$	7,106
	Amortized premiums, discounts and capitalized expenses related to indebtedness	562		491
	Estimate of interest within rental expense	7		5
	Fixed charges, as adjusted	$	7,705	$	7,602
	Ratio of earnings to fixed charges	1.57		1.16

EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer pursuant to

Section 302 of the Sarbanes-Oxley Act of 2002

I, Richard K. Matros, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Sabra Health Care REIT, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 8, 2012

/S/    RICHARD K. MATROS

Richard K. Matros

Chairman, President and

Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer pursuant to

Section 302 of the Sarbanes-Oxley Act of 2002

I, Harold W. Andrews, Jr., certify that:

1. I have reviewed this quarterly report on Form 10-Q of Sabra Health Care REIT, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 8, 2012

/S/    HAROLD W. ANDREWS, JR.

Harold W. Andrews, Jr.

Executive Vice President,

Chief Financial Officer and Secretary

EX-32.1

Exhibit 32.1

Certification pursuant to 18 U.S.C. Section 1350,

as Adopted pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Sabra Health Care REIT, Inc. (the “Registrant”) for the three months ended March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Richard K. Matros, as Chairman, President and Chief Executive Officer of the Registrant, hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Date: May 8, 2012

/S/    RICHARD K. MATROS

Richard K. Matros

Chairman, President and

Chief Executive Officer

EX-32.2

Exhibit 32.2

Certification pursuant to 18 U.S.C. Section 1350,

as Adopted pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Sabra Health Care REIT, Inc. (the “Registrant”) for the three months ended March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Harold W. Andrews, Jr., the Executive Vice President, Chief Financial Officer and Secretary of the Registrant, hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Date: May 8, 2012

/S/    HAROLD W. ANDREWS, JR.

Harold W. Andrews, Jr.

Executive Vice President,

Chief Financial Officer and Secretary

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Mar. 31, 2012

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]

Significant Accounting Policies [Text Block]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation and Basis of Presentation

The condensed consolidated financial statements include the accounts of Sabra and its wholly owned subsidiaries. All significant intercompany balances and transactions are eliminated in consolidation.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information as contained within the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and the rules and regulations of the Securities and Exchange Commission (the "SEC"), including the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for financial statements. In the opinion of management, the financial statements for the unaudited interim period presented include all adjustments, which are of a normal and recurring nature, necessary for a fair statement of the results for such period. Operating results for the three months ended March 31, 2012 are not necessarily indicative of the results that may be expected for the year ending December 31, 2012. For further information, refer to the Company’s consolidated financial statements and notes thereto for the year ended December 31, 2011 included in the Company’s 2011 Annual Report on Form 10-K filed with the SEC.

Use of Estimates

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.

Real Estate Acquisition Valuation

The Company accounts for the acquisition of income-producing real estate or real estate that will be used for the production of income as a business combination. All assets acquired and liabilities assumed in a business combination are measured at their acquisition-date fair values. Acquisition pursuit costs are expensed as incurred and restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. During the three months ended March 31, 2012, the Company expensed $0.5 million of acquisition pursuit costs, which is included in general and administrative expense on the accompanying condensed consolidated statements of income.

Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property-operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income.

Interest Income

Interest income on the Company’s loan receivable is recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination costs are amortized over the term of the loan as an adjustment to interest income. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on nonaccrual status and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines the collection of interest according to the contractual terms of the loan is probable, the Company will resume the accrual of interest. On March 15, 2012, a wholly owned subsidiary of the Company entered into the Mezzanine Loan. The Mezzanine Loan has a five year term, bears interest at a fixed rate of 11.0% per annum and is secured by the borrowers' equity interests in three skilled nursing facilities and one assisted living facility located in Texas. The Company has an option to purchase the three skilled nursing facilities and one assisted living facility before March 31, 2013 for up to an aggregate purchase price of $43.0 million and increasing 2.5% for each of the two years thereafter.

XML

BUSINESS

3 Months Ended

Mar. 31, 2012

BUSINESS [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

BUSINESS

Overview

Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) was incorporated on May 10, 2010 as a wholly owned subsidiary of Sun Healthcare Group, Inc. (“Old Sun”) and commenced operations upon completion of the Separation and REIT Conversion Merger (discussed below) on November 15, 2010 (the “Separation Date”). Sabra is organized to qualify as a real estate investment trust (“REIT”) and will elect to be treated as a REIT for U.S. federal income tax purposes upon the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. Sabra’s primary business consists of acquiring, financing and owning real estate property to be leased to third party tenants in the healthcare sector. Sabra owns substantially all of its assets and properties and conducts its operations through Sabra Health Care Limited Partnership, a Delaware limited partnership (the “Operating Partnership”), of which Sabra is the sole general partner, or by subsidiaries of the Operating Partnership. As of March 31, 2012, Sabra’s investment portfolio included 99 properties (consisting of (i) 89 skilled nursing/post-acute facilities, (ii) nine senior housing facilities, and (iii) one acute care hospital). In addition, as of March 31, 2012, a wholly owned subsidiary of the Company was the lender under a loan (the "Mezzanine Loan") secured by the borrowers' equity interests in three skilled nursing facilities and one assisted living facility located in Texas and including a purchase option on these four facilities. The Mezzanine Loan was originated on March 15, 2012 for $10.0 million.

Separation and REIT Conversion Merger

On May 24, 2010, Old Sun announced its intention to restructure its business by separating its real estate assets and its operating assets into two separate publicly traded companies, Sabra and SHG Services Inc. (which has been renamed “Sun Healthcare Group, Inc.” or “Sun”). In order to effect the restructuring, Old Sun distributed to its stockholders on a pro rata basis all of the outstanding shares of common stock of Sun (this distribution is referred to as the “Separation”), together with an additional cash distribution. Immediately following the Separation, Old Sun merged with and into Sabra, with Sabra surviving the merger and Old Sun stockholders receiving shares of Sabra common stock in exchange for their shares of Old Sun common stock (this merger is referred to as the “REIT Conversion Merger”). Effective November 15, 2010, the Separation and REIT Conversion Merger were completed and Sabra and Sun began operations as separate companies.

Following the Separation, Sun, through its subsidiaries, continued the business and operations of Old Sun and its subsidiaries. Sabra did not operate prior to the Separation. Immediately following the Separation, subsidiaries of Sabra owned substantially all of Old Sun’s owned real property. The owned real property held by subsidiaries of Sabra following the Separation includes fixtures and certain personal property associated with the real property. The historical consolidated financial statements of Old Sun became the historical consolidated financial statements of Sun at the time of the Separation. At the time of the Separation, the balance sheet of Sabra included the owned real property and mortgage indebtedness to third parties on the real property as well as indebtedness incurred by Sabra prior to completion of the Separation. The statements of income and cash flows of Sabra consist solely of its operations after the Separation. The Separation was accounted for as a reverse spinoff. Accordingly, Sabra’s assets and liabilities are recorded at the historical carrying values of Old Sun.

XML

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2011
Assets
Real estate investments, net of accumulated depreciation of $116,166 and $108,916 as of March 31, 2012 and December 31, 2011, respectively	$ 680,635	$ 658,377
Cash and cash equivalents	2,675	42,250
Restricted cash	6,664	6,093
Deferred tax assets	25,540	25,540
Prepaid expenses, deferred financing costs and other assets	31,031	17,390
Total assets	746,545	749,650
Liabilities and stockholders’ equity
Mortgage notes payable	157,603	158,398
Senior unsecured notes payable	225,000	225,000
Accounts payable and accrued liabilities	17,804	14,139
Tax liability	25,540	25,540
Total liabilities	425,947	423,077
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of March 31, 2012 and December 31, 2011	0	0
Common stock, $.01 par value; 125,000,000 shares authorized, 37,009,602 and 36,891,712 shares issued and outstanding as of March 31, 2012 and December 31, 2011, respectively	370	369
Additional paid-in capital	346,827	344,995
Cumulative distributions in excess of net income	(26,599)	(18,791)
Total stockholders’ equity	320,598	326,573
Total liabilities and stockholders’ equity	$ 746,545	$ 749,650

XML

Condensed Consolidated Statement of Stockolders' Equity Parenthetical (USD $)	3 Months Ended
	Mar. 31, 2012
Common dividends ($0.33 per share)	$ 0.33

XML

Condensed Consolidated Statement of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash flows from operating activities:
Net income	$ 4,405	$ 1,248
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	7,303	6,086
Amortization of deferred financing costs	566	495
Stock-based compensation expense	2,203	1,142
Amortization of premium on notes payable	(4)	(4)
Straight-line rental income adjustments	(969)	0
Changes in operating assets and liabilities:
Prepaid expenses and other assets	(126)	391
Accounts payable and accrued liabilities	4,053	4,106
Restricted cash	(967)	(1,006)
Net cash provided by operating activities	16,464	12,458
Cash flows from investing activities:
Acquisitions of real estate	(29,850)	0
Origination of note receivable	10,103	0
Acquisition of note receivable	0	(5,329)
Additions to real estate	(256)	(86)
Net cash used in investing activities	(40,209)	(5,415)
Cash flows from financing activities:
Principal payments on mortgage notes payable	(791)	(760)
Payments of deferred financing costs	(2,456)	(306)
Issuance of common stock	(370)	0
Dividends paid	(12,213)	0
Net cash used in financing activities	(15,830)	(1,066)
Net decrease in cash and cash equivalents	(39,575)	5,977
Cash and Cash Equivalents, beginning of period	42,250	74,233
Cash and Cash Equivalents, end of period	2,675	80,210
Supplemental disclosure of cash flow information:
Interest paid	$ 2,140	$ 2,447

XML

Condensed Consolidated Balance Sheets Parenthetical (USD $)	Mar. 31, 2012	Dec. 31, 2011
Accumulated depreciation	$ 116,166	$ 108,916
Stockholders' Equity:
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	125,000,000	125,000,000
Common stock, shares issued	37,009,602	36,891,712
Common stock, shares outstanding	37,009,602	36,891,712

XML

PRO FORMA FINANCIAL INFORMATION

3 Months Ended

Mar. 31, 2012

PRO FORMA FINANCIAL INFORMATION [Abstract]

Pro Forma Financial Information [Text Block]

PRO FORMA FINANCIAL INFORMATION

The following table summarizes, on an unaudited pro forma basis, the combined results of operations of the Company for the three months ended March 31, 2012 and 2011. The Company acquired two properties and originated the Mezzanine Loan during the three months ended March 31, 2012. The following unaudited pro forma information for the three months ended March 31, 2012 and 2011 has been prepared to give effect to these transactions and for the eleven acquisitions that occurred during 2011, as well as the offering of 11.7 million shares of common stock that closed in August 2011, as if they had occurred on January 1, 2011. This pro forma information does not purport to represent what the actual results of operations of the Company would have been had these acquisitions occurred on this date, nor does it purport to predict the results of operations for future periods (in thousands, except share and per share amounts):

	Three Months Ended March 31,
	2012		2011
Revenues	$	24,775	$	24,102
Depreciation and amortization	7,488		7,738
Net income	5,703		6,097
Net income per common share, basic	0.15		0.17
Net income per common share, diluted	0.15		0.17
Weighted-average number of common shares outstanding, basic	37,035,970		36,866,140
Weighted-average number of common shares outstanding, diluted	37,058,886		36,941,585

XML

Document and Entity Information Document	3 Months Ended
	Mar. 31, 2012	May 01, 2012
Entity Information [Line Items]
Entity Registrant Name	Sabra Health Care REIT, Inc.
Entity Central Index Key	0001492298
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		37,051,242

XML

COMMITMENTS AND CONTINGENCIES

3 Months Ended

Mar. 31, 2012

COMMITMENTS AND CONTINGENCIES [Abstract]

Commitments and Contingencies Disclosure [Text Block]

COMMITMENTS AND CONTINGENCIES

Concentration of Credit Risk

Concentrations of credit risks arise when a number of operators, tenants or obligors related to the Company’s investments are engaged in similar business activities, or activities in the same geographic region, or have similar economic features that would cause their ability to meet contractual obligations, including those to the Company, to be similarly affected by changes in economic conditions. The Company regularly monitors its portfolio to assess potential concentrations of risks.

Sun

As of March 31, 2012, 86 of the Company’s 99 real estate properties were leased to subsidiaries of Sun. During the three months ended March 31, 2012, 76% of the Company’s total revenues were derived from these leases. Sun is a publicly traded company and is subject to the informational filing requirements of the Securities Exchange Act of 1934, as amended, and is required to file periodic reports on Form 10-K and Form 10-Q with the SEC. As of March 31, 2012, Sun's continuing operations, through its subsidiaries, operated 190 inpatient centers spread across 23 states. Sun’s net revenues and adjusted earnings before interest, depreciation, amortization, restructuring costs and rent were $458.5 million and $52.3 million, respectively, for the three months ended March 31, 2012 and $466.3 million and $64.5 million, respectively, for the three months ended March 31, 2011. As of March 31, 2012, Sun’s outstanding debt, net of cash, totaled $44.7 million. As of March 31, 2012, Sun had approximately $104.8 million in liquidity, consisting of unrestricted cash and cash equivalents of $44.8 million and available borrowings of $60.0 million under Sun's revolving credit facility.

Cadia Portfolio

On August 1, 2011, the Company closed the purchase of four skilled nursing facilities (the “Cadia Portfolio”). The four skilled nursing facilities are located in Delaware, range in age from 2 to 15 years and have a combined total of 500 beds. In connection with the acquisition, the Company, through an indirect wholly owned subsidiary, entered into a new 15-year triple-net master lease agreement with the sellers (collectively, the “Cadia Tenants”). None of the Cadia Tenants are affiliated with the Company or any of its subsidiaries. As of March 31, 2012, the Company's investment in the Cadia Portfolio totaled 13% of the Company's assets, and during the three months ended March 31, 2012, 11% of the Company's total revenues were derived from the Cadia Portfolio lease. The Company believes that the financial condition and results of operations of the Cadia Tenants are more relevant to the Company’s investors than the financial statements of the Cadia Portfolio and enable investors to evaluate the credit-worthiness of the Cadia Tenants in their capacity as the tenants under the Cadia Portfolio lease. As a result, the Company has presented below unaudited summary financial information of the combined Cadia Tenants as of and for the three months ended March 31, 2012. The summary financial information presented below has been provided by the Cadia Tenants and has not been independently verified by the Company. The Company has no reason to believe that such information is inaccurate in any material respect.

	Three Months Ended March 31, 2012 (unaudited) (in thousands)
Statements of Operations
Revenues	$	14,959
Operating expenses	14,217
Net income	554
	As of March 31, 2012 (unaudited) (in thousands)
Balance Sheets
Cash and cash equivalents	$	5,950
Total current assets	10,614
Total current liabilities	7,132
Total debt	—

Other than the Company’s tenant concentrations, management believes the Company's current portfolio is reasonably diversified across healthcare related real estate and geographical location and does not contain any other significant concentration of credit risks. The Company’s portfolio of 99 real estate properties is diversified by location across 24 states. The properties in any one state did not account for more than 14% and 19%, respectively, of the Company’s total revenue during the three months ended March 31, 2012 and 2011.

Environmental

As an owner of real estate, the Company is subject to various environmental laws of federal, state and local governments. The Company is not aware of any environmental liability that could have a material adverse effect on its financial condition or results of operations. However, changes in applicable environmental laws and regulations, the uses and conditions of properties in the vicinity of the Company’s properties, the activities of its tenants and other environmental conditions of which the Company is unaware with respect to the properties could result in future environmental liabilities. Compliance with existing environmental laws is not expected to have a material adverse effect on the Company’s financial condition and results of operations as of March 31, 2012.

Indemnification Agreement

In connection with the Separation and REIT Conversion Merger, any liability arising from or relating to legal proceedings involving the Company’s real estate investments has been assumed by the Company and the Company will indemnify Sun (and its subsidiaries, directors, officers, employees and agents and certain other related parties) against any losses arising from or relating to such legal proceedings. In addition, pursuant to a distribution agreement entered into among Old Sun, the Company and Sun in connection with the Separation and REIT Conversion Merger, Sun has agreed to indemnify the Company (and the Company's subsidiaries, directors, officers, employees and agents and certain other related parties) for any liability arising from or relating to legal proceedings involving Old Sun’s healthcare business prior to the Separation, and, pursuant to the lease agreements between the Company and subsidiaries of Sun, the tenants agree to indemnify the Company for any liability arising from operations at the real property leased from the Company.

Immediately prior to the Separation, Old Sun was a party to various legal actions and administrative proceedings, including various claims arising in the ordinary course of its healthcare business, which are subject to the indemnities to be provided by Sun to the Company. While these actions and proceedings are not believed to be material, individually or in the aggregate, the ultimate outcome of these matters cannot be predicted. The resolution of any such legal proceedings, either individually or in the aggregate, could have a material adverse effect on Sun’s business, financial position or results of operations, which, in turn, could have a material adverse effect on the Company's business, financial position or results of operations if Sun or its subsidiaries are unable to meet their indemnification obligations.

Legal Matters

From time to time, the Company is party to legal proceedings that arise in the ordinary course of its business. Management is not aware of any legal proceedings where the likelihood of a loss contingency is reasonably possible and the amount or range of reasonably possible losses is material to the Company's results of operations, financial condition or cash flows.

XML

Condensed Consolidated Statements of Income (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Revenues:
Rental income	$ 23,663	$ 17,561
Interest income	64	40
Total revenues	23,727	17,601
Expenses:
Depreciation and amortization	7,303	6,086
Interest	7,698	7,597
General and administrative	4,321	2,670
Total expenses	19,322	16,353
Net income	$ 4,405	$ 1,248
Net income per common share, basic	$ 0.12	$ 0.05
Net income per common share, diluted	$ 0.12	$ 0.05
Weighted-average number of common shares outstanding, basic	37,035,970	25,136,140
Weighted-average number of common shares outstanding, diluted	37,058,886	25,211,585
Dividends per common share	$ 0.33	$ 0

XML

DEBT

3 Months Ended

Mar. 31, 2012

DEBT [Abstract]

Debt Disclosure [Text Block]

DEBT

Mortgage Indebtedness. The Company’s mortgage notes payable consist of the following (dollars in thousands):

Interest Rate Type	Principal Outstanding as of March 31, 2012 (2)		Principal Outstanding as of December 31, 2011 (2)		Weighted Average Interest Rate at March 31, 2012		Maturity Date
Fixed Rate	$	98,249	$	98,739	6.29	%	August 2015 - June 2047
Variable Rate(1)	58,858		59,159		5.50	%	August 2015
	$	157,107	$	157,898

^{(1)  Contractual interest rates under variable rate mortgages are equal to the 90-day LIBOR plus 4.5% (subject to a 1.0% LIBOR floor).} 

^{(2)  Outstanding principal balance for mortgage indebtedness does not include mortgage premium of $0.5 million as of March 31, 2012 and December 31, 2011.} 

8.125% Senior Notes due 2018. On October 27, 2010, the Operating Partnership and Sabra Capital Corporation, wholly owned subsidiaries of the Company (the “Issuers”), issued $225.0 million aggregate principal amount of senior, unsecured notes (the “Senior Notes”) in a private placement. The Senior Notes were sold at par, resulting in gross proceeds of $225.0 million and net proceeds of approximately $219.9 million after deducting commissions and expenses. On December 6, 2010, substantially all of the net proceeds were used by Sun to redeem the $200.0 million in aggregate principal amount outstanding of Old Sun’s 9.125% senior subordinated notes due 2015, including accrued and unpaid interest and the applicable redemption premium. In March 2011, the Issuers completed an exchange offer to exchange the Senior Notes for substantially identical 8.125% senior unsecured notes registered under the Securities Act of 1933, as amended (also referred to herein as the “Senior Notes”).

The obligations under the Senior Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by Sabra and certain of Sabra’s other existing and, subject to certain exceptions, future subsidiaries; provided, however, that such guarantees are subject to release under certain customary circumstances.  See "Note 9. Summarized Condensed Consolidating Information" for additional information concerning the circumstances pursuant to which the guarantors will be automatically and unconditionally released from their obligations under the guarantees.

The Senior Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, on or after November 1, 2014, at the redemption prices set forth in the indenture governing the Senior Notes (the “Indenture”), plus accrued and unpaid interest to the applicable redemption date. In addition, prior to November 1, 2014, the Issuers may redeem all or a portion of the Senior Notes at a redemption price equal to 100% of the principal amount of the Senior Notes redeemed, plus a “make-whole” premium, plus accrued and unpaid interest to the applicable redemption date. At any time, or from time to time, on or prior to November 1, 2013, the Issuers may redeem up to 35% of the principal amount of the Senior Notes, using the proceeds of specific kinds of equity offerings, at a redemption price of 108.125% of the principal amount to be redeemed, plus accrued and unpaid interest, if any, to the applicable redemption date. Assuming the Senior Notes are not redeemed, the Senior Notes mature on November 1, 2018.

The Indenture governing the Senior Notes contains restrictive covenants that, among other things, restrict the ability of Sabra, the Issuers and their restricted subsidiaries to: (i) incur or guarantee additional indebtedness; (ii) incur or guarantee secured indebtedness; (iii) pay dividends or distributions on, or redeem or repurchase, their capital stock; (iv) make certain investments or other restricted payments; (v) sell assets; (vi) create liens on their assets; (vii) enter into transactions with affiliates; (viii) merge or consolidate or sell all or substantially all of their assets; and (ix) create restrictions on the ability of Sabra and its restricted subsidiaries to pay dividends or other amounts to Sabra. The Indenture governing the Senior Notes also provides for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the Senior Notes, the failure to comply with certain covenants and agreements specified in the Indenture for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then outstanding Senior Notes may become due and payable immediately. As of March 31, 2012, the Company was in compliance with all applicable financial covenants under the Senior Notes.

Secured Revolving Credit Facility. On November 3, 2010, the Operating Partnership and certain subsidiaries of the Operating Partnership (together with the Operating Partnership, the “Borrowers”) entered into a secured revolving credit facility with certain lenders as set forth in the related credit agreement and Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer (each as defined in such credit agreement). The secured revolving credit facility is secured by, among other things, a first priority lien against certain of the properties owned by certain of the Company’s subsidiaries. The obligations of the Borrowers under the secured revolving credit facility are guaranteed by the Company and certain of its subsidiaries. On February 10, 2012, the Borrowers amended the secured revolving credit facility (the “Amended Secured Revolving Credit Facility”) to increase the borrowing capacity from $100.0 million to $200.0 million (up to $20.0 million of which may be utilized for letters of credit) and to include an accordion feature that allows the Borrowers to increase borrowing availability under the Amended Secured Revolving Credit Facility by up to an additional $150.0 million, subject to certain terms and conditions. Borrowing availability under the Amended Secured Revolving Credit Facility is subject to a borrowing base calculation based on, among other factors, the lesser of (i) the mortgageability cash flow (as such term is defined in the credit agreement ) or (ii) the appraised value, in each case of the properties securing the Amended Secured Revolving Credit Facility. The entire $200.0 million was available for borrowing under the Amended Secured Revolving Credit Facility as of March 31, 2012. Borrowing availability under the Amended Secured Revolving Credit Facility terminates, and all borrowings mature, on February 10, 2015, subject to a one-year extension option. As of March 31, 2012, there were no amounts outstanding on the Company’s Amended Secured Revolving Credit Facility.

Borrowings under the Amended Secured Revolving Credit Facility bear interest on the outstanding principal amount at a rate equal to an applicable percentage plus, at the Borrowers' option, either (a) LIBOR or (b) a base rate determined as the greater of (i) the federal funds rate plus 0.5%, (ii) the prime rate, and (iii) one-month LIBOR plus 1.0% (the “Base Rate”). The applicable percentage for borrowings will vary based on the Consolidated Leverage Ratio, as defined in the amended credit agreement, and will range from 2.00% to 3.00% per annum for borrowings at the Base Rate and 3.00% to 4.00% per annum for LIBOR based borrowings. In addition, the Borrowers are required to pay a facility fee to the lenders equal to between 0.35% and 0.50% per annum based on the amount of unused borrowings under the Amended Secured Revolving Credit Facility. During the three months ended March 31, 2012, the Company incurred $0.2 million of unused facility fees.

The Amended Secured Revolving Credit Facility contains customary covenants that include restrictions on the ability to make acquisitions and other investments, pay dividends, incur additional indebtedness, engage in non-healthcare related business activities, enter into transactions with affiliates and sell or otherwise transfer certain assets as well as customary events of default. The Amended Secured Revolving Credit Facility also requires the Company, through the Borrowers, to comply with specified financial covenants, which include a maximum leverage ratio, a minimum fixed charge coverage ratio and a minimum tangible net worth requirement. As of March 31, 2012, the Company was in compliance with all applicable financial covenants under the Amended Secured Revolving Credit Facility.

During the three months ended March 31, 2012 and 2011, the Company incurred interest expense of $7.7 million and $7.6 million, respectively. Included in interest expense for the three months ended March 31, 2012 and 2011, was $0.6 million and $0.5 million, respectively, of deferred financing costs amortization. As of March 31, 2012 and December 31, 2011, the Company had $8.4 million and $4.0 million, respectively, of accrued interest included in accounts payable and accrued liabilities on the accompanying condensed consolidated balance sheets.

The following is a schedule of maturities for the Company’s outstanding debt as of March 31, 2012 (in thousands):

	Mortgage Indebtedness  (1)		Senior Notes		Amended Secured Revolving Credit Facility		Total
April 1, 2012 through December 31, 2012	$	2,413	$	—	$	—	$	2,413
2013	3,428		—		—		3,428
2014	3,649		—		—		3,649
2015	86,048		—		—		86,048
2016	1,689		—		—		1,689
Thereafter	59,880		225,000		—		284,880
	$	157,107	$	225,000	$	—	$	382,107

⁽¹⁾  Outstanding principal balance for mortgage indebtedness does not include mortgage premium of $0.5 million as of March 31, 2012.

XML

REAL ESTATE INVESTMENTS

3 Months Ended

Mar. 31, 2012

Real Estate Investments [Abstract]

Real Estate Disclosure [Text Block]

REAL ESTATE INVESTMENTS

The Company’s investments in real estate consisted of the following (dollars in thousands):

As of March 31, 2012

Property Type	Number of Properties	Number of Beds/Units	Total Real Estate at Cost		Accumulated Depreciation			Total Real Estate Investments, Net
Skilled Nursing/Post-Acute	89	10,154	$	687,473	$	(105,903	)	$	581,570
Senior Housing	9	773	47,449		(8,582		)	38,867
Acute Care Hospital	1	70	61,640		(1,616		)	60,024
	99	10,997	796,562		(116,101		)	680,461
Corporate Level			239		(65		)	174
			$	796,801	$	(116,166	)	$	680,635

As of December 31, 2011

Property Type	Number of Properties	Number of Beds/Units	Total Real Estate at Cost		Accumulated Depreciation			Total Real Estate Investments, Net
Skilled Nursing/Post-Acute	87	10,034	$	658,222	$	(99,570	)	$	558,652
Senior Housing	9	773	47,192		(8,140		)	39,052
Acute Care Hospital	1	70	61,640		(1,154		)	60,486
	97	10,877	767,054		(108,864		)	658,190
Corporate Level			239		(52		)	187
			$	767,293	$	(108,916	)	$	658,377

	March 31, 2012			December 31, 2011
Building and improvements	$	650,784		$	626,877
Furniture and equipment	44,546			44,045
Land improvements	4,640			4,640
Land	96,831			91,731
	796,801			767,293
Accumulated depreciation	(116,166		)	(108,916		)
	$	680,635		$	658,377

Operating Leases

All of the Company’s real estate properties are leased under triple-net operating leases with expirations ranging from 9 to 23 years. As of March 31, 2012, the leases have a weighted-average remaining term of 12 years. The leases include provisions to extend the lease terms and other negotiated terms and conditions. The Company, through its subsidiaries, retains substantially all of the risks and benefits of ownership of the real estate assets leased to the tenants. In addition, the Company may receive additional security under these operating leases in the form of security deposits from the lessee or guarantees from the parent of the lessee. As of March 31, 2012, 86 of the Company's 99 real estate properties were leased to subsidiaries of Sun. For further discussion of the Company’s tenant and revenue concentration, see “Note 11. Commitments and Contingencies—Concentration of Credit Risk.”

As of March 31, 2012, the future minimum rental income from the Company’s properties under non-cancelable operating leases is as follows (in thousands):

April 1, 2012 through December 31, 2012	$	73,536
2013	98,048
2014	98,048
2015	98,048
2016	98,048
Thereafter	676,676
	$	1,142,404

XML

SUBSEQUENT EVENTS

3 Months Ended

Mar. 31, 2012

Subsequent Events [Abstract]

Subsequent Events [Text Block]

SUBSEQUENT EVENTS

The Company evaluates subsequent events up until the date the condensed consolidated financial statements are issued.

Dividend Declaration

On April 24, 2012, the Company’s board of directors declared a quarterly cash dividend of $0.33 per share of common stock. The dividend will be paid on May 31, 2012 to stockholders of record as of May 15, 2012.

XML

EARNINGS PER COMMON SHARE

3 Months Ended

Mar. 31, 2012

EARNINGS PER COMMON SHARE [Abstract]

Earnings Per Share [Text Block]

EARNINGS PER COMMON SHARE

The following table illustrates the computation of basic and diluted earnings per share for the three months ended March 31, 2012 and 2011 (in thousands, except share and per share amounts):

	Three Months Ended March 31,
	2012		2011
Numerator
Net income	$	4,405	$	1,248
Denominator
Basic weighted average common shares	37,035,970		25,136,140
Dilutive stock options and restricted stock units	22,916		75,445
Diluted weighted average common shares	37,058,886		25,211,585
Basic earnings per common share	$	0.12	$	0.05
Diluted earnings per common share	$	0.12	$	0.05

Restricted stock and certain of the Company’s performance restricted stock units are considered participating securities which require the use of the two-class method when computing basic and diluted earnings per share. During the three months ended March 31, 2012 and 2011, approximately 0.2 million and 0.5 million restricted stock units, respectively, and options to purchase approximately 0.4 million shares were not included because they were anti-dilutive.

XML

FAIR VALUE DISCLOSURES

3 Months Ended

Mar. 31, 2012

Fair Value Disclosures [Abstract]

FairValueDisclosure [Text Block]

FAIR VALUE DISCLOSURES

The fair value for certain financial instruments is derived using a combination of market quotes, pricing models and other valuation techniques that involve significant management judgment. The price transparency of financial instruments is a key determinant of the degree of judgment involved in determining the fair value of the Company’s financial instruments.

Financial instruments for which actively quoted prices or pricing parameters are available and whose markets contain orderly transactions will generally have a higher degree of price transparency than financial instruments whose markets are inactive or consist of non-orderly trades. The Company evaluates several factors when determining if a market is inactive or when market transactions are not orderly. The carrying values of cash and cash equivalents, restricted cash, accounts payable and accrued liabilities are reasonable estimates of fair value because of the short-term maturities of these instruments. Fair values for other financial instruments are derived as follows:

Mezzanine Loan: This instrument is presented in the accompanying condensed consolidated balance sheets at its amortized cost and not at fair value. The fair value of the Mezzanine Loan was estimated using an internal valuation model that considered the expected cash flows for the Mezzanine Loan, the underlying collateral value and other credit enhancements.

Senior Notes: The fair values of the Senior Notes were determined using third-party market quotes derived from orderly trades.

Mortgage indebtedness: The fair values of the Company’s notes payable were estimated using a discounted cash flow analysis based on management’s estimates of current market interest rates for instruments with similar characteristics, including remaining loan term, loan-to-value ratio, type of collateral and other credit enhancements.

The following are the carrying amounts and fair values of the Company’s financial instruments as of March 31, 2012 and December 31, 2011 whose carrying amounts do not approximate their fair value:

	March 31, 2012						December 31, 2011
	Face Value (1)		Carrying Amount (2)		Fair Value		Face Value (1)		Carrying Amount (2)		Fair Value
Financial assets:
Mezzanine Loan	$	10,000	$	10,128	$	10,000	$	—	$	—	$	—
Financial liabilities:
Senior Notes	225,000		225,000		237,938		225,000		225,000		227,813
Mortgage indebtedness	157,107		157,603		171,583		157,898		158,398		172,829

⁽¹⁾ Face value represents amounts contractually due under the terms of the respective agreements.

⁽²⁾ Carrying amounts represent the book value of financial instruments and include unamortized premiums (discounts).

The Company determined the fair value of financial instruments as of March 31, 2012 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands):

			Fair Value Measurements Using
			Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
Financial assets:
Mezzanine Loan	$	10,000	$	—	$	—	$	10,000
Financial liabilities:
Senior Notes	$	237,938	$	—	$	237,938	$	—
Mortgage indebtedness	$	171,583	$	—	$	—	$	171,583

Disclosure of the fair value of financial instruments is based on pertinent information available to the Company at the applicable dates and requires a significant amount of judgment. Despite increased capital market and credit market activity, transaction volume for certain financial instruments remains relatively low. This has made the estimation of fair values difficult and, therefore, both the actual results and the Company’s estimate of fair value at a future date could be materially different.

During the three months ended March 31, 2012, the Company measured the following assets at fair value with valuation methods utilizing the following types of inputs (in thousands):

			Fair Value Measurements Using
			Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
Nonrecurring Basis:
Investments in real estate (1)	$	29,850	$	—	$	—	$	29,850

⁽¹⁾ Amount reflects acquisition date fair value of real estate acquired in 2012.

The significant unobservable inputs used in the measurement of the Company's real estate acquisition date fair value include comparable transaction prices for similar properties, market lease rates, discount rates and lease-up periods. Significant increases or decreases in any of these inputs in isolation would result in a significantly different fair value measurement.

XML

EQUITY

3 Months Ended

Mar. 31, 2012

Equity [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

EQUITY

Common Stock

The following table lists the cash dividends on common stock declared and paid by the Company during the three months ended March 31, 2012:

Declaration Date	Record Date	Amount Per Share		Dividend Payable Date
February 29, 2012	March 15, 2012	$	0.33	March 30, 2012

On April 24, 2012, the Company announced that its board of directors declared a quarterly cash dividend of $0.33 per share of common stock. The dividend will be paid on May 31, 2012 to stockholders of record as of the close of business on May 15, 2012.

On August 1, 2011, the Company completed an underwritten public offering of 11.7 million newly issued shares of its common stock pursuant to a registration statement filed with the SEC, which became effective on July 26, 2011.  The Company received net proceeds, before expenses, of $163.9 million from the offering, after giving effect to the issuance and sale of all 11.7 million shares of common stock (which included 1.5 million shares sold to the underwriters upon exercise of their option to purchase additional shares to cover over-allotments), at a price to the public of $14.75 per share.

During the three months ended March 31, 2012, the Company issued 117,890 shares of common stock as a result of restricted stock unit vestings and in connection with incentive bonus payments payable under the Company's 2011 Bonus Plan pursuant to an election to receive the bonus payment in shares of the Company's common stock.

XML

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION

3 Months Ended

Mar. 31, 2012

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION [Abstract]

Condensed Financial Information of Parent Company Only Disclosure [Text Block]

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION

In connection with the offering of the Senior Notes by the Issuers in October 2010, the Company and certain 100% owned subsidiaries of the Company (the “Guarantors”) have, jointly and severally, fully and unconditionally guaranteed the Senior Notes, subject to release under certain customary circumstances as described below. These guarantees are subordinated to all existing and future senior debt and senior guarantees of the Guarantors and are unsecured. The Company conducts all of its business through and derives virtually all of its income from its subsidiaries. Therefore, the Company’s ability to make required payments with respect to its indebtedness (including the Senior Notes) and other obligations depends on the financial results and condition of its subsidiaries and its ability to receive funds from its subsidiaries.

A Guarantor will be automatically and unconditionally released from its obligations under the guarantees with respect to the Senior Notes in the event of:

• Any sale of the subsidiary Guarantor or of all or substantially all of its assets;

• A merger or consolidation of a subsidiary Guarantor with an issuer of the Senior Notes or another Guarantor, provided that the surviving entity remains a Guarantor;

• A subsidiary Guarantor is declared "unrestricted" for covenant purposes under the Indenture;

• The requirements for legal defeasance or covenant defeasance or to discharge the Indenture have been satisfied;

• A liquidation or dissolution, to the extent permitted under the Indenture, of a subsidiary Guarantor; and

• The release or discharge of the guaranty that resulted in the creation of the subsidiary guaranty, except a discharge or release by or as a result of payment under such guaranty.

Pursuant to Rule 3-10 of Regulation S-X, the following summarized consolidating information is provided for the Company (the “Parent Company”), the Issuers, the Guarantors, and the Company’s non-Guarantor subsidiaries with respect to the Senior Notes. This summarized financial information has been prepared from the books and records maintained by the Company, the Issuers, the Guarantors and the non-Guarantor subsidiaries. The summarized financial information may not necessarily be indicative of the results of operations or financial position had the Issuers, the Guarantors or non-Guarantor subsidiaries operated as independent entities. Sabra’s investments in its consolidated subsidiaries are presented based upon Sabra's proportionate share of each subsidiary's net assets. The Guarantor subsidiaries’ investments in the non-Guarantor subsidiaries and non-Guarantor subsidiaries’ investments in Guarantor subsidiaries are presented under the equity method of accounting. Intercompany activities between subsidiaries and the Parent Company are presented within operating activities on the condensed consolidating statement of cash flows.

Condensed consolidating financial statements for the Company and its subsidiaries, including the Parent Company only, the Issuers, the combined Guarantor subsidiaries and the combined non-Guarantor subsidiaries, are as follows:

CONDENSED CONSOLIDATING BALANCE SHEET

March 31, 2012

(in thousands, except share and per share amounts)

(unaudited)

	Parent Company			Issuers		Combined Guarantor Subsidiaries		Combined  Non- Guarantor Subsidiaries		Elimination			Consolidated
Assets
Real estate investments, net of accumulated depreciation	$	175		$	—	$	498,583	$	181,877	$	—		$	680,635
Cash and cash equivalents	1,634			—		—		1,041		—			2,675
Restricted cash	—			—		—		6,664		—			6,664
Deferred tax assets	25,540			—		—		—		—			25,540
Prepaid expenses, deferred financing costs and other assets	995			4,893		22,211		2,932		—			31,031
Intercompany	1,049			145,017		—		27,634		(173,700		)	—
Investment in subsidiaries	322,261			404,968		24,195		—		(751,424		)	—
Total assets	$	351,654		$	554,878	$	544,989	$	220,148	$	(925,124	)	$	746,545
Liabilities and stockholders’ equity
Mortgage notes payable	$	—		$	—	$	—	$	157,603	$	—		$	157,603
Senior unsecured notes payable	—			225,000		—		—		—			225,000
Accounts payable and accrued liabilities	5,516			7,617		3,805		866		—			17,804
Tax liability	25,540			—		—		—		—			25,540
Intercompany	—			—		173,700		—		(173,700		)	—
Total liabilities	31,056			232,617		177,505		158,469		(173,700		)	425,947
Stockholders’ equity:
Preferred stock, $.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of March 31, 2012	—			—		—		—		—			—
Common stock, $.01 par value; 125,000,000 shares authorized, 37,009,602 shares issued and outstanding as of March 31, 2012	370			—		—		—		—			370
Additional paid-in capital	346,827			289,452		316,978		52,313		(658,743		)	346,827
Cumulative distributions in excess of net income	(26,599		)	32,809		50,506		9,366		(92,681		)	(26,599		)
Total stockholders’ equity	320,598			322,261		367,484		61,679		(751,424		)	320,598
Total liabilities and stockholders’ equity	$	351,654		$	554,878	$	544,989	$	220,148	$	(925,124	)	$	746,545

CONDENSED CONSOLIDATING BALANCE SHEET

December 31, 2011

(in thousands, except share and per share amounts)

	Parent Company			Issuers		Combined Guarantor Subsidiaries		Combined  Non- Guarantor Subsidiaries		Elimination			Consolidated
Assets
Real estate investments, net of accumulated depreciation	$	187		$	—	$	474,256	$	183,934	$	—		$	658,377
Cash and cash equivalents	41,736			—		—		514		—			42,250
Restricted cash	—			—		—		6,093		—			6,093
Deferred tax assets	25,540			—		—		—		—			25,540
Prepaid expenses, deferred financing costs and other assets	874			5,079		8,544		2,893		—			17,390
Intercompany	—			145,018		—		25,237		(170,255		)	—
Investment in subsidiaries	313,181			391,131		23,611		—		(727,923		)	—
Total assets	$	381,518		$	541,228	$	506,411	$	218,671	$	(898,178	)	$	749,650
Liabilities and stockholders’ equity
Mortgage notes payable	$	—		$	—	$	—	$	158,398	$	—		$	158,398
Senior unsecured notes payable	—			225,000		—		—		—			225,000
Accounts payable and accrued liabilities	6,296			3,047		4,107		689		—			14,139
Tax liability	25,540			—		—		—		—			25,540
Intercompany	23,109			—		147,146		—		(170,255		)	—
Total liabilities	54,945			228,047		151,253		159,087		(170,255		)	423,077
Stockholders’ equity:
Preferred stock, $.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of December 31, 2011	—			—		—		—		—			—
Common stock, $.01 par value; 125,000,000 shares authorized, 36,891,712 shares issued and outstanding as of December 31, 2011	369			—		—		—		—			369
Additional paid-in capital	344,995			288,665		316,011		52,110		(656,786		)	344,995
Cumulative distributions in excess of net income	(18,791		)	24,516		39,147		7,474		(71,137		)	(18,791		)
Total stockholders’ equity	326,573			313,181		355,158		59,584		(727,923		)	326,573
Total liabilities and stockholders’ equity	$	381,518		$	541,228	$	506,411	$	218,671	$	(898,178	)	$	749,650

CONDENSED CONSOLIDATING STATEMENT OF INCOME

For the Three Months EndedMarch 31, 2012

(in thousands, except share and per share amounts)

(unaudited)

	Parent Company			Issuers			Combined Guarantor Subsidiaries			Combined  Non- Guarantor Subsidiaries		Elimination			Consolidated
Revenues:
Rental income	$	—		$	—		$	17,215		$	6,448	$	—		$	23,663
Interest income	6			—			58			—		—			64
Total revenues	6			—			17,273			6,448		—			23,727
Expenses:
Depreciation and amortization	12			—			5,232			2,059		—			7,303
Interest	—			4,757			463			2,478		—			7,698
General and administrative	3,882			—			419			20		—			4,321
Income in subsidiary	(8,293		)	(13,050		)	(202		)	—		21,545			—
Total expenses	(4,399		)	(8,293		)	5,912			4,557		21,545			19,322
Net income	$	4,405		$	8,293		$	11,361		$	1,891	$	(21,545	)	$	4,405
Net income per common share, basic															$	0.12
Net income per common share, diluted															$	0.12
Weighted-average number of common shares outstanding, basic															37,035,970
Weighted-average number of common shares outstanding, diluted															37,058,886

CONDENSED CONSOLIDATING STATEMENT OF INCOME

For the Three Months Ended March 31, 2011

(in thousands, except share and per share amounts)

(unaudited)

	Parent Company			Issuers			Combined Guarantor Subsidiaries			Combined  Non- Guarantor Subsidiaries		Elimination			Consolidated
Revenues:
Rental income	$	—		$	—		$	11,270		$	6,291	$	—		$	17,561
Interest income	28			—			12			—		—			40
Total revenues	28			—			11,282			6,291		—			17,601
Expenses:
Depreciation and amortization	15			—			3,939			2,132		—			6,086
Interest	—			4,749			322			2,526		—			7,597
General and administrative	2,631			—			2			37		—			2,670
Income in subsidiary	(3,866		)	(8,615		)	(94		)	—		12,575			—
Total expenses	(1,220		)	(3,866		)	4,169			4,695		12,575			16,353
Net income	$	1,248		$	3,866		$	7,113		$	1,596	$	(12,575	)	$	1,248
Net income per common share, basic															$	0.05
Net income per common share, diluted															$	0.05
Weighted-average number of common shares outstanding, basic															25,136,140
Weighted-average number of common shares outstanding, diluted															25,211,585

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the Three Months Ended March 31, 2012

(in thousands)

(unaudited)

	Parent Company			Issuers		Combined Guarantor Subsidiaries			Combined  Non- Guarantor Subsidiaries			Elimination			Consolidated
Net cash provided by operating activities	$	15,369		$	—	$	—		$	1,095		$	—		$	16,464
Cash flows from investing activities:
Acquisitions of real estate	—			—		(29,850		)	—			—			(29,850		)
Origination of note receivable	—			—		(10,103		)	—			—			(10,103		)
Additions to real estate	—			—		(256		)	—			—			(256		)
Investment in Subsidiary	(728		)									728			—
Net cash used in investing activities	(728		)	—		(40,209		)	—			728			(40,209		)
Cash flows from financing activities:
Principal payments on mortgage notes payable	—			—		—			(791		)	—			(791		)
Payments of deferred financing costs	—			—		(2,296		)	(160		)	—			(2,456		)
Payments related to the issuance of common stock	(370		)	—		—			—			—			(370		)
Dividends paid	(12,213		)	—		—			—			—			(12,213		)
Contribution from Parent	—			—		—			728			(728		)	—
Distribution to Parent	—			—		—			(345		)	345			—
Distribution from Subsidiary	345			—		—			—			(345		)	—
Intercompany financing	(42,505		)	—		42,505			—			—			—
Net cash provided by (used in) financing activities	(54,743		)	—		40,209			(568		)	(728		)	(15,830		)
Net decrease in cash and cash equivalents	(40,102		)	—		—			527			—			(39,575		)
Cash and cash equivalents, beginning of period	41,736			—		—			514			—			42,250
Cash and cash equivalents, end of period	$	1,634		$	—	$	—		$	1,041		$	—		$	2,675

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the Three Months Ended March 31, 2011

(in thousands)

(unaudited)

	Parent Company			Issuers		Combined Guarantor Subsidiaries		Combined  Non- Guarantor Subsidiaries			Elimination		Consolidated
Net cash provided by operating activities	$	8,038		$	—	$	—	$	4,420		$	—	$	12,458
Cash flows from investing activities:
Acquisition of note receivable	(5,329		)	—		—		—			—		(5,329		)
Additions to real estate	(86		)	—		—		—			—		(86		)
Net cash used in investing activities	(5,415		)	—		—		—			—		(5,415		)
Cash flows from financing activities:
Principal payments on mortgage notes payable	—			—		—		(760		)	—		(760		)
Payments of deferred financing costs	(306		)	—		—		—			—		(306		)
Intercompany financing	3,636			—		—		(3,636		)	—		—
Net cash provided by (used in) financing activities	3,330			—		—		(4,396		)	—		(1,066		)
Net decrease in cash and cash equivalents	5,953			—		—		24			—		5,977
Cash and cash equivalents, beginning of period	70,841			—		—		3,392			—		74,233
Cash and cash equivalents, end of period	$	76,794		$	—	$	—	$	3,416		$	—	$	80,210

XML

Condensed Consolidated Statement of Stockholders' Equity (USD $) In Thousands, except Share data	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Cumulative Distributions in Excess of Net Income [Member]
Balance at Dec. 31, 2010	$ 177,533	$ 251	$ 177,275	$ 7
Common Stock, Shares, Outstanding at Dec. 31, 2010		25,061,072
Net income	1,248			1,248
Amortization of stock based compensation	1,142		1,142
Stock Issuance, Shares		23,662
Stock Issuance, Value	0	0	0
Balance at Mar. 31, 2011	179,923	251	178,417	1,255
Common Stock, Shares, Outstanding at Mar. 31, 2011		25,084,734
Balance at Dec. 31, 2011	326,573	369	344,995	(18,791)
Common Stock, Shares, Outstanding at Dec. 31, 2011	36,891,712	36,891,712
Net income	4,405			4,405
Amortization of stock based compensation	2,203		2,203
Stock Issuance, Shares		117,890
Stock Issuance, Value	(370)	1	(371)
Common dividends ($0.33 per share)	(12,213)			(12,213)
Balance at Mar. 31, 2012	$ 320,598	$ 370	$ 346,827	$ (26,599)
Common Stock, Shares, Outstanding at Mar. 31, 2012	37,009,602	37,009,602

XML

RECENT ACQUISITIONS OF REAL ESTATE

3 Months Ended

Mar. 31, 2012

RECENT ACQUISITIONS OF REAL ESTATE [Abstract]

Business Combination Disclosure [Text Block]

ACQUISITIONS OF REAL ESTATE

During the three months ended March 31, 2012, the Company acquired two skilled nursing facilities for a total purchase price of $29.9 million. The purchase price was allocated as follows (in thousands):

				Intangibles
Land		Building and Improvements		Tenant Origination and Absorption Costs		Tenant Relationship		Total Purchase Price
$	5,100	$	24,150	$	500	$	100	$	29,850

As of March 31, 2012, the purchase price allocations for these properties are preliminary pending the receipt of information necessary to complete the valuation of certain tangible and intangible assets and liabilities and therefore are subject to change.

The tenant origination and absorption costs intangible assets and tenant relationship intangible assets acquired in connection with these acquisitions have weighted-average amortization periods as of the date of acquisition of 15 years and 25 years, respectively.

For the three months ended March 31, 2012, the Company recognized $18,000 of total revenues from these properties.